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ABSTRACT

MYO1C BINDS TO PIP2 WITH HIGH AFFINITY THROUGH A PUTATIVE
PH DOMAIN

David Hokanson

Dr. E. Michael Ostap

Myo1c is a member of the myosin superfamily that links the dynamic actin cytoskeleton to the
membrane, and plays roles in mechano-signal transduction and membrane trafficking. We located and
characterized two distinct membrane binding sites within the regulatory and tail domains of this myosin.
We found that the tail domain binds tightly and specifically to PIP 2 in a non-cooperative manner. It binds
with slightly higher affinity to Ins(1,4,5)P 3 as well as other inositol phosphates which may act as
inhibitors to membrane binding in the cell. By sequence and secondary structure analysis, we identified
this phosphatidylinositol binding site in the tail to be a putative pleckstrin homology (PH) domain. Point
mutations of residues known to be essential for phosphatidylinositol binding in previously characterized
PH domains inhibit myo1c binding to PIP 2 in vitro and eradicate correct localization and membrane
binding in vivo. The extended sequence of this binding site is conserved within many other myosin-Is
across species, suggesting they also contain a putative PH domain. We also characterized a previously
identified membrane binding site within the IQ motifs in the regulatory domain. This region is not
phosphatidylinositol specific, but binds anionic phospholipids in a Ca 2+ dependent manner; nevertheless,
this site is not essential for in vivo membrane binding. As a result, we have determined that myo1c
contains two lipid binding sites, a polybasic region that binds to high levels of PS in a Ca2+ dependent
manner and a putative PH domain that binds tightly and specifically to phosphatidylinositols.
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Preface
When I was looking for a graduate school, while finishing my undergrad
degrees at Ohio University, I didn’t know what to expect. I was in complete disbelief
after I took my GRE that schools were actually going to pay ME to go to school instead
of the other way around. Initially, I selected just two schools to apply to based on the
protein folding research that was being done by the faculty, and avoiding any of the
pompous Ivy-league schools. I was fortunately unaware at the time that the University
of Pennsylvania was, in fact, an Ivy-league school, or I would never have applied. My
girlfriend at the time hid this from me, and for that I am grateful. When I discovered
the truth a fortnight before my interview, I almost cancelled, but instead I reserved my
prejudice and came anyway. I was shocked at how collaborative and non-cutthroat
Penn was. It seemed to have all the success and prestige I envisioned an Ivy-league
school to have, but was also laid back and friendly. My interview went well and I knew
this was where I would end up for the next five to seven years of my life.
Mercifully, it has only taken me five years to finish my thesis; although, I have
never been in a hurry to leave Philly or Penn. The best decision I could have made was
working for Dr. Mike Ostap. I was Mike’s first graduate student, yet it seemed as
though he had mentored hundreds before me. I truly believe that much of my happiness
here at Penn is due to having a great mentor and lab environment. For anyone that has
watched the NBC show, “Scrubs”, Mike is my Dr. Cox. He picks on me constantly and
never quite gives me that pat on the back I yearn for, but inspires me to work even
harder to get it. To me, Mike is much more than just a brilliant boss who has all the
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answers and is rarely wrong, he is a truly inspiring human being. I can’t think of a
better man to look up to professionally.
There are many people at Penn that I owe some part of my sanity to, including
the faculty on my committee and in the PMI, fellow graduate students, and Ruth and
Angie in the department offices. After my prelim, I was worried about picking such
well-established faculty to serve on my thesis committee for fear that they would make
my life hell.

However, with each committee meeting I learned that their vast

knowledge and expertise in my field were indispensable and made my work more
forthright, not more grueling. Also, I’ve made some great friends here and without
them, finishing graduate school would have been a much more menacing feat. Thank
you fellow BMB students.
The Ostap lab is smaller than most labs, and I think that was beneficial to me as
a beginning graduate student. I would like to thank current and past members of the
lab, in particular, Nanyung, Tianming, Joe, and Jennine. Nanyung was a postdoc when
I started in the lab and played a hand in training me to do many of the things I now take
for granted (I just wish some of her cloning magic wore off on me). Tianming, what
isn’t there to say about Tianming. He is an invaluable member of the lab to me and
everyone else. Never complaining, always willing to help, and an absolute master of
what he does everyday. Thank you Tianming for constantly keeping the lab stocked
with protein and helping in every way you can. Joe has given me the much needed
comic relief I’ve needed to get through the frustrating days over the years. You’ve
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always been there to ask the stupid questions I’m too embarrassed to ask Mike. Jennine
has been a very welcomed new addition to the lab. I’m thrilled there is someone to take
over my project at least in part when I depart. I have enjoyed trying to play the role of a
mentor and it is humanitarian of you to always laugh at my jokes.
And lastly I would like to thank my family and extended family, my friends.
Dad, you always said you would buy me a car if I followed in your footsteps and
graduated from med school. Well, I’m graduating from the University of Pennsylvania
School of Medicine, it’s a technicality I know, but I’ll take what I can get. Thank you
for always believing in me and supporting me through undergrad and the rough times
since. Liz, I’m so glad we are still as close as ever. Your support at the beginning and
now has always meant so much to me. I am ecstatic that you are ecstatic for me. Oh
and I guess thanks for the help with Illustrator too. Bryan, you’ve always been a great
friend here at Penn: may we continue to brew great beer and times together for many
years. And of course a big thank you to my beautiful girlfriend Sarah (Dorkface). I
know I’m probably more difficult than you’ve ever imagined, but I hope it has been
worth it for you because it certainly has been for me. Your English major background
has been a big help with the editing, but it doesn’t come close to the mental and
emotional clutch you have been…when I let you. Thank you to everyone, I love you
all. “All right, brain, I don’t like you and you don’t like me, so let’s just do this and I’ll
get back to killing you with beer.” Homer Simpson.
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1 Introduction
1.1 Objective
The myosin super-family is very diverse and expands well beyond the typical
myosin II stereotype found in muscle. Most characterized myosins are able to bind
actin filaments through their motor domain, possess ATPase activity, and are able to
generate force. Humans express 40 different myosin genes that differ in the kinetics of
their motor domains, and the cargo binding of their tail domains.

Eight of these

myosins are class-I isoforms. It has been known since 1989 that myosin-I isoforms
associate with anionic lipids, yet the specificity and lipid binding site(s) were not
known. The overall purpose of this dissertation was to characterize the interaction of a
myosin-I motor with the plasma membrane. The focus of this thesis is myo1c, a single
headed, membrane associated isoform that is found in most eukaryotic cells and is
involved in membrane dynamics, cytoskeletal structure, and mechano-signal
transduction.

Little was known of the mechanism by which myo1c bound to the

membrane or what kinds of forces it could generate once anchored to the fluid bilayer.
Knowing the specificity and mechanism of how a myosin-I interacts with lipids was
essential for understanding the possible functions of an actin-based motor bound to the
plasma membrane. Therefore, my aim was to characterize the protein-lipid interactions
in much greater detail.

1.2 Summary
Myo1c is a member of the myosin superfamily that links the dynamic actin
cytoskeleton to the membrane, and plays roles in mechano-signal transduction and

membrane trafficking. We located and characterized two distinct membrane binding
sites within the regulatory and tail domains of this myosin. We found that the tail
domain binds tightly and specifically to PIP2 in a non-cooperative manner. It binds
with slightly higher affinity to Ins(1,4,5)P3 as well as other inositol phosphates which
may act as inhibitors to membrane binding in the cell. By sequence and secondary
structure analysis, we identified this phosphatidylinositol binding site in the tail to be a
putative pleckstrin homology (PH) domain. Point mutations of residues known to be
essential for phosphatidylinositol binding in previously characterized PH domains
inhibit myo1c binding to PIP2 in vitro and eradicate correct localization and membrane
binding in vivo. The extended sequence of this binding site is conserved within many
other myosin-Is across species, suggesting they also contain a putative PH domain. We
also characterized a previously identified membrane binding site within the IQ motifs in
the regulatory domain.

This region is not phosphatidylinositol specific, but binds

anionic phospholipids in a Ca2+ dependent manner; nevertheless, this site is not essential
for in vivo membrane binding. As a result, we have determined that myo1c contains
two lipid binding sites, a polybasic region that binds to high levels of PS in a Ca2+
dependent manner and a putative PH domain that binds tightly and specifically to
phosphatidylinositols.
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1.3 Background
1.3.1 Myosin

Myosins are molecular motors that convert the chemical energy from ATP to a
mechanical force along actin filaments in the cell. Conventional myosin, myosin-II,
was the first molecular motor to be discovered and has been studied for many decades
due to its fundamental role in muscle contraction. Myosin-II is a two-headed molecule
that oligomerizes into bipolar filaments, which slide relative to actin filaments to create
a contraction in muscle cells. In 1973, the first unconventional myosin, Acanthamoeba
myosin-I, was discovered (Pollard and Korn 1973). There are now 24 classes of
myosins identified (Figure 1) (Foth, Goedecke et al. 2006) with humans expressing 40
different myosin genes.

Mutations in myosin genes lead to a variety of diseases

including myopathies, hearing loss, and blindness. Myosins are involved in a large
number of cellular processes, such as muscle contraction, cell motility, cytokinesis,
phagocytosis, growth cone extension, maintenance of cell shape, mechano-signal
transduction, endocytosis, exocytosis, and organelle/particle trafficking.

3

Figure 1 Myosin Family Tree

Figure 1: The most recent phylogenetic tree of the myosin super family from (Foth,
Goedecke et al. 2006). It was created from a representative distance matrix-based
phylogeny (PROTDIST_NEIGHBOR) of myosin head domains. Listed are the 24
classes of myosin motors that have been identified. Note that the largest family
consists of members of the myosin-I family.
4

1.3.1.1 Myosin Domain Structure

All characterized members of the myosin super family contain a head, neck and
tail domain (Figure 2). The head domain is an 80 kDa catalytic motor, which binds to
actin and hydrolyzes ATP to induce a powerstroke. The degree of conservation varies
among families and isoforms, and results in observed enzymatic differences in the
ATPase cycle of the myosin. The neck domain is an extended α-helical light chainbinding region consisting of one or more IQ motifs, which have a 23 residue consensus
sequence IQXXXRGXXXRK.

These IQ motifs bind to light chains, such as

calmodulin (CaM), or other EF-hand proteins that stiffen the α-helix and regulate the
myosin in a Ca2+ dependent manner (Zhu, Beckingham et al. 1998). The neck domain
serves as a lever arm that transduces small conformational changes in the motor domain
to larger displacements. The tail domain is varied among the different myosin isoforms
and in many cases determines the localization and function of the myosin. The tail
domain exhibits class-specific properties such as filament forming, dimerizing, cargo
binding, or kinase activity (Mooseker and Cheney 1995). This thesis will focus on the
regulatory and tail domain of myo1c, a class I myosin.

5

Figure 2 Myosin Structure

Figure 2: Model of myosin-II bound to actin from (Holmes, Schroder et al. 2004).
Crystal structure of myosin–II bound to a modeled actin filament, which is shown
on the left. Myosin-II is shown in A) pre-powerstroke, and B) post-powerstroke
conformations. The 80 kDa head domain is shown in red, cyan, yellow and green,
and the regulatory domain is shown in blue with light chains (purple and yellow)
bound. The tail domain is not present in this structure.
6

1.3.1.2 Myosin ATPase Cycle

Myosin motors bind and hydrolyze ATP to convert chemical energy to a
mechanical force used to translocate actin filaments (Figure 3). Myosin in a nucleotidefree state remains tightly bound to actin in what is referred to as the rigor state. Upon
ATP binding, myosin enters a weak actin binding state and dissociates from the
filament. ATP is hydrolyzed and the myosin lever arm is cocked into a pre-powerstroke
conformation. Upon binding to actin, phosphate (Pi) is released and the lever arm is
moved forward during the powerstroke as myosin enters the strong binding state. ADP
is released, which results in a second sub-step for some isoforms, and the myosin
returns to the rigor state. A new ATP molecule is now able to bind to the myosin motor
to repeat the cycle. Although all myosins follow this cycle, the kinetics and regulation
of these steps can differ greatly between myosin families and even isoforms. The rate
limiting step for myosin-I motors is Pi release, which means that myosin-Is most often
exist in the weakly bound state. However, they have been proposed to enter a state of
isometric contraction that prevents ADP release under stall forces, which may increase
their lifetime bound to actin (Batters, Arthur et al. 2004). This proposed function of
myosin-Is to act as a tension sensor will be further discussed throughout.

7

Figure 3 Myosin ATPase cycle

Figure 3: The ATPase cycle of a myosin motor is shown as A) a
cartoon model, and B) a kinetic scheme from (Murphy, Rock et al.
2001). Strong actin bound states are shown in red, whereas weak
actin bound states are shown in blue. Note, the powerstroke is
depicted as occurring after Pi release; however, this point remains to
be settled (Dantzig, Goldman et al. 1992; Takagi, Homsher et al.
2006).
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1.3.1.3 Ca2+ Regulation of Light Chains

Most characterized myosins contain one or more IQ motifs in their regulatory
domain that bind to EF-containing light chains in a Ca2+ dependent manner. These light
chains are thought to structurally stabilize the regulatory domain, which is a long αhelix that would be flaccid without light chains bound. In the case of many myosins,
this light chain is CaM, which contains two lobes, each containing two EF hand motifs
that can each bind to two Ca2+ ions (Figure 4). CaM undergoes a conformational
change when Ca2+ binds, which in most cases lowers the affinity of CaM for the IQ
motifs, and can even lead to dissociation of the CaM. For myosin-Is, this is proposed to
reveal positively charged residues within the IQ motifs, which can then bind through
electrostatic interactions to the negatively charged phospholipids in the plasma
membrane (Swanljung-Collins and Collins 1992; Tang, Lin et al. 2002; Hirono, Denis
et al. 2004); although, this property has not been shown to be physiologically relevant.
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Figure 4 CaM Bound to IQ Peptide

Figure 4: Structure of two apo-CaM light chains bound to a
portion of the regulatory domain consisting of 6 adjacent IQ
motives of myosin-V. Two CaM light chains, cyan and green, are
shown bound a section of the regulatory domain, magenta,
containing two adjacent IQ motifs (PDB 2IX7).
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1.3.2 Myosin-I

Myosin-Is comprise the largest unconventional myosin family in humans (Berg,
Powell et al. 2001) where they function in membrane dynamics, cell structure,
endocytosis, and mechanical signal transduction (Ruppert, Godel et al. 1995; Tang and
Ostap 2001; Bose, Guilherme et al. 2002; Holt, Gillespie et al. 2002; Tyska, Mackey et
al. 2005; Sokac, Schietroma et al. 2006). They are single-headed myosins that do not
dimerize or form filaments. The IQ motifs in the regulatory domain of all vertebrate
myosin-Is each bind to a CaM. The tail domains of myosin-Is are highly basic and bind
to anionic lipids in the plasma membrane. Myosin-Is can be further divided into two
sub-classes, the short-tail and long-tail isoforms. The long-tail isoforms have two
additional protein:protein interaction domains, a src homology 3 (SH3) and a glycineproline-rich domain.

Vertebrates express six short-tail myosin-Is (myo1a, myo1b,

myo1c, myo1d, myo1g) and two long-tail isoforms (myo1e, myo1f) (Berg, Powell et al.
2001).

1.3.2.1 Localization of Myosin-I

Subcellular fractionations of vertebrate cells show that a large percentage of
myosin-I is associated with the membrane and the cytoskeletal fractions (Ruppert,
Godel et al. 1995; Bose, Guilherme et al. 2002; Cho, Kim et al. 2005), and
immunofluorescence and live cell microscopy suggest that myosin-I is dynamically
localized to the cell membrane. Thus, a key property of myosin-I isoforms appears to
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be their ability to bind in a regulated manner to cellular membranes (Coluccio 1997;
Tang and Ostap 2001).

1.3.2.2 History of Myosin-I Membrane Association

The association of myosin-I with anionic lipids has been studied since the late
1980s. In 1989, Pollard showed that Acanthamoeba myosin-I bound to both extracted
membranes and to vesicles of pure lipids (Adams and Pollard 1989) and Korn found
that Acanthamoeba myosin-I localized to the plasma membrane (Miyata, Bowers et al.
1989). A year later, Mooseker discovered that a vertebrate myosin-I, myo1a, bound to
anionic lipid vesicles through its tail domain (Hayden, Wolenski et al. 1990), which
Pollard also found to be true of Acanthamoeba myosin-I (Doberstein and Pollard 1992).
Since then, many laboratories have shown through in vivo experiments that myosin-I
isoforms associate with anionic phospholipids (Hirono, Denis et al. 2004; Huang,
Lifshitz et al. 2004). Kinetic studies of myo1c showed that association rates with acidic
large unilamellar vesicles (LUVs) were diffusion limited, whereas the dissociation rates
depended on the ratio of PS to myo1c-tail and was slower than the myo1c ATPase rate
(Tang, Lin et al. 2002).
Since myosin-Is are able to bind to both the cell membrane and actin, this leads
to many possible mechanical functions. A dynamic link between the actin cytoskeleton
and membrane can be formed. This could deform the membrane, form barriers, or form
micro-domains around proteins in the membrane with the cytoskeleton acting much like
12

a fence around cattle, supplying support and rigidity. Myosin-Is could also bind to
endocytic vesicles and transport them along an actin track, or aid in retrograde flow.
One of the molecular roles that has become more characterized in recent years is the
role of myo1c as a mechanical signal transducer in hair cells (Batters, et al. 2004).
Although there are many hypotheses in the scientific community, there is still
little evidence as to what myosin-Is can functionally do while bound to the membrane.
Therefore, the goal of this thesis was to characterize the interactions of a particular
myosin-I isoform, myo1c, with the plasma membrane, thus leading to a better
understanding of its molecular roles as a link between the plasma membrane and the
cytoskeleton.

1.3.3 Myo1c

Myo1c has been shown to play roles in lamellipodial retraction, endosomal
processing, glucose transportation, and mechanical signal transduction. It is widely
expressed in vertebrate cell types and is largely localized to the plasma membrane and
cytoskeleton (Ruppert, Godel et al. 1995; Bose, Guilherme et al. 2002; Cho, Kim et al.
2005). This is especially true at specialized dynamic membrane structures such as
lamellipodia, microvilli, endocytic structures and inner-ear hair cell stereocilia. Myo1c
has also been shown to be enriched in micro domains through proteonimics analysis
(Saeki, Miura et al. 2003). However, the functions and regulation of myo1c while
bound to the plasma membrane are still unknown.
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1.3.3.1 Possible Functions of Myo1c

Myo1c being able to bind to both the cell membrane and actin leads to many
possible mechanical functions. These functions include tethering the cytoskeleton to
the membrane, translocating actin in the plane of the membrane, deforming or
rearranging membrane structures, and acting as a tension sensor. Although many of the
biological roles of myo1c are poorly understood, the one role that has become better
characterized in recent years is the role of myo1c as a mechanical signal transducer in
hair cells of the inner ear.

1.3.3.2 Myo1c Catalytic Activity

In order to hypothesize about the possible functions of myo1c while bound to
the membrane, it is important to first review its biochemical properties.

Myo1c

hydrolyzes ATP at a rate of 0.1 – 1 s-1 and has a low duty ratio of 0.05 under no load
(Gillespie, Gillespie et al. 1999). This means that myosin will be in a strong actin
binding state only 5% of the time. Actin activates the ATPase rate by 2 – 10 fold, and
the actin motility rate has been measured at 100 nm/s (Batters, Arthur et al. 2004). Ca2+
appears to affect the motility of myo1c by altering its mechanical activity; moreover,
some laboratories have found that Ca2+ increases actin activated ATPase activity
(Barylko, Wagner et al. 1992; Batters, Arthur et al. 2004). These effects are most likely
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due to Ca2+ binding to and changing the conformation of CaM light chains bound to the
IQ motifs in the regulatory domain.
The powerstroke of myo1c seems to occur in two phases. The first substep of
~3 nm correlates with the release of Pi, whereas the second substep of ~1 nm
corresponds to ADP release (Batters, Arthur et al. 2004). This is supported by electron
microscopy data showing a large difference in the position of the neck domain between
ADP-bound and nucleotide free states (Batters, Arthur et al. 2004). The kinetics of
myo1c seem to be load dependent (Batters, Arthur et al. 2004). Since nucleotide release
and mechanical states are coupled, one explanation for the motor domain being unable
to release ADP is myo1c arrest after the first substep, staying strongly bound to ADP
and maintaining tension. This would cause the myo1c to remain bound in an isometric
contraction until either the load is released and it is able to proceed through its catalytic
cycle, or the load increases and myo1c is forced back into a ADP.Pi-like state in which
it will detach from actin (Batters, Arthur et al. 2004). However, the role of myo1c as a
tension sensor still needs to be demonstrated.
1.3.4 Biological Roles

Myo1c has been implicated through biochemical and cell biological techniques
to be involved in many different cellular processes. Many laboratories have shown the
importance of myo1c function at areas in the cell where the cytoskeleton and membrane
interact. However, aside from its role as a mechano-signal transducer in hair cells, no
precise functional data has been demonstrated for myo1c at the plasma membrane.
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Characterizing how myo1c interacts with the membrane will give insight to its role in
the following biological processes.
1.3.4.1 Compensatory Endocytosis

Egg activation in Xenopus and several other vertebrates is induced upon
fertilization by an increase in intracellular Ca2+. This initiates several events, one of
which is cortical granule exocytosis which is required to block polysperm. Cortical
granule containing vesicles lie just beneath the plasma membrane until fertilization.
Upon activation, they fuse with the membrane and exocytosis commences. To prevent
the membrane from growing due to the fusion of cortical granule vesicles,
compensatory endocytosis takes place just after vesicle fusion. This process involves
an actin coat forming around the fused vesicles and compressing it to retrieve the
vesicle (Sokac, Schietroma et al. 2006).
Myo1c is upregulated by polyadenylation during meiotic maturation in Xenopus
eggs. Upon fertilization, myo1c is recruited to the cortical granule containing vesicle
preceding actin coat assembly. Inhibition of myo1c leads to an uncoupling of the actin
coats from the exocytosing cortical granules, resulting in failure of compensatory
endocytosis. There is also an increase in polymerization of actin at the membrane
throughout the cell. These findings suggest that myo1c couples the barbed ends of actin
to the membrane, mediating force production from the polymerizing actin during
compensatory endocytosis, rather than directly producing force through a powerstroke
(Sokac, Schietroma et al. 2006). This requires a specific localization of myo1c to sites
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of endocytosis as well as a strong link to the plasma membrane to support the actin coat
and forces of polymerization.
1.3.4.2 Glucose Exocytosis

Insulin stimulates the uptake of glucose in muscle and adipocytes by inducing
the translocation and exocytosis of vesicles containing the glucose transporter protein,
GLUT4. This process is required for maintaining normal blood glucose levels. GLUT4
translocation requires the actin cytoskeleton.

Rapid and directed movement along

filaments implicates the involvement of myosin motors, most likely myosin-V (Bose,
Guilherme et al. 2002). Phosphatidylinositol-4,5-bisphosphate (PIP2) has also been
shown to stimulate the glucose transport activity of GLUT4 at the plasma membrane
(Funaki, DiFransico et al. 2006). These results suggest that PIP2 acts as a second
messenger to activate release of GLUT4 through the remodeling of the actin
cytoskeleton.
Cells lacking myo1c have a reduced glucose uptake (Bose, Guilherme et al.
2002).

Over-expression reverses the effect of inhibiting phosphoinositol-3 kinase

(PI3K), which inhibits GLUT4-containing vesicles and causes them to accumulate right
below the plasma membrane. Over-expression also induced membrane ruffling in
adipocytes which is normally induced by insulin. GLUT4-containing vesicles have
been shown to colocalize with myo1c only at the membrane, suggesting that myo1c is
not involved in translocating vesicles to the membrane, but rather in anchoring them to
the membrane, fusing them to the membrane, or exocytosis (Bose, Guilherme et al.
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2002). Glucose exocytosis clearly requires both PIP2 and myo1c to be present at the
membrane for proper function.

1.3.4.3 Neuronal Growth Cone Extension

Neurons extend growth cones from the tips of growing axons to form a precise
pattern in the nervous system.

They have the ability to maneuver through the

developing nervous system which is enabled by both actin and microtubule-based
mechanisms. Protrusion of the lamellipodia and filopodia at the cell periphery is known
to be actin-based. Several myosin motors have been implicated in this process (Wang,
Wolenski et al. 1996; Wylie, Wu et al. 1998). Inhibition of myosin-V causes retraction
of filopodia, whereas inhibition of myosin-II causes reduction in the size of the
lamellipodia.
Inactivation of myo1c in chick dorsal root ganglion results in lamellipodial
extension by actin polymerization (Diefenbach, Latham et al. 2002).

When this

rearward movement of actin is inhibited, the lamellipodia extends forward unchecked.
Using chromophore assisted laser inactivation, areas of the lamellipodia where myo1c
was inactivated would polymerize and extend, causing the neuron to steer in that
direction (Wang, Liu et al. 2003). This suggests that myo1c has an effect on actin
polymerization, or possibly acts to translocate actin filaments rearward.

The

localization and regulation of myo1c at areas of lamellipodial extension remain unclear.
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1.3.4.4 Hair Cells

The most knowledge on a molecular role of myo1c is its role in the stereocilia of
hair cells as a mechano-sensing transducer. Hair cells contain bundles of 30 – 300
actin–filled stereocilia arranged in a tiered arrangement (Figure 5).

Auditory or

vestibular stimuli, caused by sound or head movements, cause the individual stereocilia
to move with respect to one another, which results in the opening and closing of
transduction channels. When the channels open, cations, K+ and Ca2+, rush into the
stereocilia, which depolarizes the cell and causes a neurotransmitter to be released. The
channels then close causing the cell to hyper-polarize and cease the release of the
neurotransmitter (Gillespie 2004). The channels are opened by tension placed on them
by an extracellular tip link composed of a filament of cadherin 23 that is connected to
the tip of an adjacent stereocilia (Siemens, Lillo et al. 2004).
Hair cells are able to adapt after being initially displaced to retain the same
intrinsic sensitivity but operate over a higher range of movements. This suggested that
there was a change in the mechanical arrangement within the bundles during adaptation.
For this to occur, the tip link from one bundle must be able to slide down the
stereocilium of a neighboring stereocilium to reduce the tension felt by the channel and
allow it to close. During periods of no simulation, the channel would have to relocate
back to its original position to restore tension. This model seemed like a perfect fit for
myosin-I (Howard and Hudspeth 1987). Two forms of adaptation have been described
to occur in hair cells concurrently under distinct mechanisms. A fast adaptation of a
few milliseconds for channel closing suggests that Ca2+ entering through the channel
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signals them to shut. A slow adaptation of 20 ms is thought to be myosin-I based (Holt,
Gillespie et al. 2002).
In the hair cells of developing mice, although stereocilia have formed, no
sensory activity is present until embryonic day 16. This correlates precisely with the
formation of tip links and the expression of myo1c (Geleoc and Holt 2003). Three
components have been found to be essential for adaptation and transduction in hair
cells, PIP2, cadherin 23, and myo1c (Hirono, Denis et al. 2004; Siemens, Lillo et al.
2004). Myo1c has been shown to bind to both cadherin 23 and PIP2 (Phillips, Tong et
al. 2006). These interactions allow myo1c to link the transduction apparatus to the
bundled actin filaments. Under resting conditions, stereocilia are upright with resting
tension from the tip links on the transduction channels. Myo1c bound to actin and the
transduction complex remains in an isometric contraction, keeping the channel closed.
When stereocilia move in relation to each other, tension is produced and the tip link
pulls open the transduction channel as myo1c is forced into an ADP.Pi-like state,
releases from actin, and slides down the actin bundle. During the adaptation discussed
above, myo1c motors, now at the beginning of their catalytic cycle, rebind and climb
the actin bundle under zero load until tension is restored, thus closing the channel
(Batters, Arthur et al. 2004). Therefore, myo1c is responsible for allowing the channels
to open under tension, and then closing them by restoring tension (Gillespie 2004).
From data showing that the tip link complex can withstand up to 80 pN of force before
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breaking, it has been estimated that up to 50 myosin motors are required per tip link
(Hudspeth and Gillespie 1994).

Figure 5 Hair cell

Figure 5: Figure is from (Hirono, Denis et al. 2004).
Immunogold electron microscopy of hair cell in intact
saccular epithelium using a monoclonal antibody for PIP2,
2C11, without subtilisin treatment and with fixative-saline
permeabilization. Scale bar, 500 nm.
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1.3.5 Myo1c Binding Partners

The tail domains of myosin are generally known as the cargo binding domains.
Many efforts have been made to identify proteins that bind to the tail domain of myo1c
with little success. Proteins that bind to the regulatory or tail domain of myo1c could be
important for its sub-cellular localization and non-redundant functions from other
myosin-I isoforms.

Binding partners could incorporate myo1c into larger protein

complexes needed to form at the plasma membrane, or could require myo1c for proper
positioning at the membrane. They could also regulate lipid binding or affect the
kinetics of membrane association or dissociation. To date, only three proteins have
been found: cadherin 23, NEMO, and PHR1.

1.3.5.1 Cadherin 23

Cadherin 23 is a component of the tip link complex in hair cells.

The

cytoplasmic domain of cadherin 23 was shown to colocalize and immunoprecipate with
myo1c when coexpressed in HEK cells (Siemens, Lillo et al. 2004). This interaction
functions to link the adaptive motor to the transduction channel in stereocilia. More on
this function will be discussed later.

1.3.5.2 NEMO

Nuclear factor κB essential modulator (NEMO) is a subunit of the IκB kinase
complex which attenuates insulin action by phosphorylating the insulin receptor
substrate.

NEMO was found to accumulate at membrane ruffles preceding an
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interaction with the insulin receptor substrate. Location of NEMO is dependent on
insulin, actin and myo1c. Over-expression of myo1c enhanced the interaction between
NEMO and insulin receptor substrate, while expression of a dominate negative tail
domain of myo1c inhibited insulin receptor substrate phosphorylation. NEMO and
myo1c were shown to interact through both endogenous and recombinant
immunoprecipation from cell extracts (Nakamori, Emoto et al. 2006). It is thought that
myo1c helps localize NEMO at the plasma membrane so that it can form a complex to
the insulin receptor in order to pacify insulin action through phosphorylation.

1.3.5.2 PHR1

PHR1 is an integral membrane protein found in photoreceptor cells, olfactory
receptor neurons, and hair cells. It has four different splice isoforms that can be
expressed, and contains a PH domain that lacks the signature motif containing basic
residues required for phosphatidylinositol binding.

PHR1 interacts with the tail

domains of myo1c and myoVIIa through this PH domain as evidenced by
immunoprecipitation and a yeast two hybrid interaction (myo1c only) (Etournay, ElAmraoui et al. 2005). Although its role in hair cells is unclear, it has potential functions
in post golgi protein trafficking and possibly the mechano-transduction slow adaptation
process through its interaction with myo1c.
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1.3.6 The Plasma Membrane

To characterize the interaction of myo1c with the membrane, it is important to
consider the role of different lipids that make up the inner leaflet.

The plasma

membrane in most cells is made up of transmembrane proteins and a variety of
phospholipids which include phosphatidyl choline (PC), phosphatidyl serine (PS),
phosphatidyl ethanolamine (PE), phosphatidyl inositol (PI), and phosphatidic acid (PA).
PC and PE are neutral Zwitterions, whereas PS, PA, and PI carry a negative charge. PI
can be phosphorylated in the cell by phospholipid kinases to produce PIP, PIP 2 and
PIP3, which carry multiple negative charges on a single headgroup. These PIs are
locally concentrated in regions of the cell and act as signaling second messengers and
substrates for proteins that localize to the plasma membrane. There are no naturally
basic phospholipids, and because of this, the levels of PS and PIs in the inner leaflet can
confer a substantial negative charge (DiNitto, Cronin et al. 2003).
The three phospholipids that were used in this dissertation are PC, PS, and PIP2
(Figure 6). The vesicles in our experiments were comprised of PC, which is neutral,
and was used as a background.

PS was used as the standard negatively charged

phospholipid in the inner leaflet of the plasma membrane. It has an effective charge of
negative one and is found in vivo at ~20-30%. PIP2 is used as the primary multivalent
phospholipid. Its concentration at the plasma membrane is 100-fold greater than other
poly-phosphatidylinositols, and it is the anchor for many membrane bound proteins, as
well as a source for second messengers diacylglycerol (DAG) and inositol-1,4,5trisphosphate (Ins(1,4,5)P3).
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Figure 6 Phospholipids

Figure 6: Structures of the phospholipids used in this
dissertation, from avantilipids.com. Space filling models are
shown above chemical structures.
identified by (-).
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Negative charges are

1.3.7 PIP2

PIP2 is the major poly-phosphatidylinositol in mammalian cells. Its physical
properties, organization and role in signaling are involved in many cell processes that
occur at the membrane. The biochemical and biophysical properties of this essential
phospholipid and its interactions with proteins at the plasma membrane will be briefly
reviewed here. For a full review, refer to (McLaughlin, Wang et al. 2002).

1.3.7.1 Structure and Charge

PIP2 contains a DAG tail that is linked to the phosphate at the 1 position of an
inositol ring that is also phosphorylated at the 4 and 5 positions. The pK values are 6.7
and 7.7 respectively. The protonation states vary depending on the binding of proteins
as well as the pH and ionic strength of the environment. Consequently, the net charge
of PIP2 can range from -3 to -4 due to the protonation states of these phosphate groups.

1.3.7.2 Biological Roles of PIP2

PIP2 was initially studied as the source of two second messengers in the cell,
DAG and Ins(1,4,5)P3, which go on to activate PKC and release Ca2+ from the
endoplasmic reticulum respectively. It is now known that PIP2 is important for the
membrane localization of proteins. The attachment of these proteins to PIP2 is essential
to their role in cytoskeleton dynamics, exocytosis, endocytosis, membrane trafficking,
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and the activation of enzymes (Yin and Janmey 2003).

Many laboratories have

proposed that the existence of high local concentrations of PIP2 within the cell are
responsible for some of these functions. PIP2 and other phosphaphatidylinositides are
in fact distributed non-uniformly in the plasma membrane. Moreover, PIP2 has been
found to be abundant in certain regions of the plasma membrane, including stereocilia,
membrane ruffles, macropinocytes, and nascent phagosomes (McLaughlin, Wang et al.
2002; Huang, Lifshitz et al. 2004).

1.3.7.3 PIP2 Concentration

PIP2 is anabolized and catabolized by a number of different kinases,
phosphatases, and lipases, and can also be sequestered by a plethora of PIP2 binding
proteins in the cell (Figure 7). It comprises >99% of the doubly phosphorylated
phosphatidylinositols in a mammalian cell, yet it makes up only ~1% of the
phospholipids in the inner leaflet of the plasma membrane. Assuming a typical cell
with a radius of 10 µm has an effective total lipid concentration of 1 mM, the effective
concentration of PIP2 would be ~10 μM (McLaughlin, Wang et al. 2002). However,
this would not be the concentration of PIP2 available since there are many proteins in
the cell that bind to and sequester PIP2.
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Figure 7 PIP2 metabolism

Figure 7: A schematic of PIP2 metabolism adapted from (Rusten and
Stenmark 2006). Inositol rings of biological phosphoinositols are drawn
with DAG attached to the Pi at the “1” position. Arrows between structures
are labeled with appropriate kinases and phosphatases.
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1.3.8 Membrane Binding Domains

There are numerous strategies that proteins have developed to bind to the
membrane (DiNitto, Cronin et al. 2003). They range from the very specific binding
interaction of phospholipase C delta pleckstrin homology (PLCδ-PH) domain with PIP2
to the non-specific interaction of myristoylated alanine rich C kinase substrate
(MARCKS).

To understand the localization and how myo1c functions at the

membrane, it is essential to first understand how it is associated with the membrane.
These two extremes of binding will be discussed below.

1.3.8.1 MARCKS

MARCKS contains a polybasic effector domain (ED) which binds to the plasma
membrane (Figure 8). The ED of MARCKS has been well studied, and contains 13
basic residues, five phenylalanines, and a myristoylated N-terminus. MARCKS has no
set structure when it is bound or unbound to the membrane (Arbuzova, Schmitz et al.
2002).

MARCKS also binds to CaM and actin; these interactions, along with

phosphorylation, inhibit it from binding to the membrane. Myristoylation, hydrophobic
insertions, and electrostatic interactions all contribute to membrane binding, and make
MARCKS an eminent example for non-specific membrane association.
Electrostatic interactions mainly contribute to MARCKS binding to the
membrane.

This is accomplished by the polybasic region of the ED having an

electrostatic attraction with the negatively charged inner leaflet of the plasma
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membrane. The negative charge is made up from PS and phosphatidyl inositols, the
most abundant of which is PIP2. These negatively charged lipids anchor the cluster of
basic residues in the ED to the membrane. Partition coefficients increase linearly in
binding studies done with increasing the percent of acidic lipid (Arbuzova, Wang et al.
2000; Lemmon and Ferguson 2001).
These electrostatic interactions were found to be very non-specific.

The

individual residues and lipids were inconsequential, as long as the residues were
positively charged arginines or lysines, and the lipids were negative. Studies done with
R/K mutants and K/R mutants showed no effects on membrane binding (Wang,
Gambhir et al. 2002). It has also been shown that peptides with stretches of arginine or
lysine bind just as well to a negative membrane as a protein made up with the same
number of basic residues (Wang, Gambhir et al. 2002). The only time this differs is
when the protein has a rigid structure, and is able to make the same amount of contacts
with fewer basic residues per total residues. It has also been shown that MARCKS has
no preference for PS or phosphatidyl glycine (PG), which has the same negative charge.
However, MARCKS does bind preferentially to PIP2, as the partition coefficient is the
same with 20% PS as it is with only 1% PIP2 (Wang, Arbuzova et al. 2001). This
preference for PIP2 over singularly charged phospholipids enables the polybasic ED of
MARCKS to laterally sequester PIP2 into micro domains.

Through fluorescence

experiments with physiological concentrations of 33% PS, MARCKS has been shown
to bring together numerous PIP2 molecules (Wang, Gambhir et al. 2002).
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Figure 8 MARKS peptide

Figure 8: A representation of MARCKS binding to the plasma
membrane, adapted from (Gambhir, Hangyas-Mihalyne et al.
2004). MARCKS is shown as a green snake. The position of
positively charged residues are denoted by white crosses. Nterminal myristoylation is represented by an orange squiggly
tongue.

Brown hexagons are hydrophobic residues that insert

into the membrane. Lipids shown are: PC, white; PS, fuschia;
PIP2, blue.
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1.3.8.2 Pleckstrin Homology (PH) Domains

PH domains are the 11th most common domain found in the human proteome
(Lemmon 2007). There are more than 250 proteins that contain one or more PH
domains. They were first identified in numerous membrane associated proteins with
sequence homology to pleckstrin, a protein kinase C (PKC) substrate. PH domains are
made up of ~120 residues and contain a β-sandwich consisting of 7 β-strands. This βcore is capped at one open end by a C-terminal α-helix, leaving three hypervariable
loops at the other end to interact with binding partners (Figure 9). It was originally
thought that all PH domains bound to phosphatidylinositols in cell membranes, although
with varying affinities and specificities. It is now known that some PH domains do not
bind to phosphatidylinositols, but instead to proteins (Lemmon 2007). An example of
this is PHR1, which binds to the tail domains of myo1c and myoVIIa (Etournay, ElAmraoui et al. 2005).
Many PH domains contain a specific binding pocket for the phosphorylated
inositol rings of phosphatidyl inositols.

These pockets are made up of multiple

hypervariable loops that form hydrogen bonds to the phosphates on the inositol rings of
phosphatidyl inositols (Figure 10) (Lemmon and Ferguson 2001). The first of these
loops between β-strand 1 and β-strand 2 is where the PH domain signature motif lies.
Slight variations in the non conserved residues found on these loops give rise to the
binding specificity to particular phosphatidyl inositols (Cronin, DiNitto et al. 2004).
The binding pockets of poly-phosphoinoitol binding (PPB) PH domains can bind
stereo-specifically to a specific phosphatidyl inositol, while others bind promiscuously
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to many phosphatidyl inositols. The crystal structures of many PH domains have been
solved with the inositol phosphates bound in between the hypervariable loops.

Figure 9 PLCδPH domain

Figure 9: A crystal structure of PLCδ-PH domain bound to
Ins(1,4,5)P3 imposed in a model plasma membrane. The inositol
from the crystal structure represents the blue head domain of
PIP2. The structure of PLCδ-PH was drawn with Pymol.
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Figure 10 PH domain H-bonds

Figure 10: A close up of the crystal structure from Figure 9 drawn
with Pymol. Details are shown of hydrogen bonds from arginines
and lysines in hypervariable loop one to the phosphates on
Ins(1,4,5)P3.
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2 Materials and Methods
This chapter will discuss all of the materials, equipment, and methods used to
complete this thesis including: equipment, reagents and buffers, molecular biology,
tissue culture, protein detection, protein preparations, assays, analysis of data, and
modeling.

2.1 Equipment
Fast phase liquid chromatography (FPLC), ÄKTA Basic UPC (Amersham
Biosciences); fluorimeter, (PTI, Birmingham, NJ); UV-visible spectrophotometer, Cary
50 Bio (Varian); microscope setup: Leica DMIRB microscope fitted with a Nikon 1.45
NA objective lens (Axelrod, 2001), 488 nm 43 series argon laser (Melles Griot), C474295 digital camera (Hamamatsu), computer controlled filter wheel (Sutter Instruments);
centrifuges: TL ultracentrifuge (Optima), L8-M ultracentrifuge (Beckman), RC-5B
superspeed centrifuge (Sorvall), J6-HC swinging bucket (Beckman); gel scanner, 8600
imager (Typhoon); scintillation counter, LS 6000 SC (Beckman); film developer, XOMAT 2000A Processor (Kodak); Orbital Shaker (Forma Scientific).

2.2 Reagents and Buffers
All in vitro experiments were performed in HNa100 (10 mM HEPES, pH 7.0,
100 mM NaCl, 1 mM EGTA, 1 mM DTT) unless otherwise stated. Ca2+ concentrations
were adjusted by adding CaCl2 to HNa100 and are reported as free Ca2+ using EGTA as
a chelator.

Unless stated otherwise, all experiments done with myosin constructs

containing at least one IQ motif were performed with 1 M free CaM.
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Phosphatidylserine (PS), phosphatidylcholine (PC), and phosphatidylinositol-4,5bisphosphate (PIP2) were purchased from Avanti Polar Lipids (Alabaster, AL); D-myoinositol-1,4,5-trisphosphate

(Ins(1,4,5)P3),

D-myo-inositol-1,3,4,5-tetrakisphosphate

(Ins(1,3,4,5)P4), D-myo-inositol-1,3,4,6-tetrakisphosphate (Ins(1,3,4,6)P4), and D-myoinositol hexakisphosphate (InsP6) were purchased from Calbiochem (La Jolla, Ca); Dmyo-inositol-3-monophosphate

(Ins(3)P1)

D-myo-inositol-1,3,4-trisphosphate

(Ins(1,3,4)P3), and D-myo-inositol-1,2,6-trisphosphate (Ins(1,2,6)P3) were purchased
from Cayman Chemical (Ann Arbor, MI); D-myo-inositol-1,2,5,6-tetrakisphosphate
(Ins(1,2,5,6)P4) and D-myo-inositol-1,2,3,5,6-pentakisphosphate (Ins(1,2,3,5,6)P5) were
purchased from A.G. Scientific (San Diego, Ca). Tritiated inositol-1,4,5-trisphosphate
(3H-Ins(1,4,5,)P3) was purchased from Perkin Elmer.

Anti-GFP rabbit serum was

purchased by Invitrogen. Secondary antibodies, ECL anti-rabbit IgG and anti-mouse
IgG were purchased from Amersham Biosciences.

2.3 Molecular Biology
2.3.1 Constructs

All constructs used are listed along with their domain structure (Figure 11).
Myo1c-tail, myo1c (residues 690-1028); myo1c-motor, myo1c (residues 1-767); GFPmyo1c, GFP-tagged full length myo1c; GFP-tail, GFP-tagged myo1c (residues 6901028); GFP-tailIQ2–3, GFP-tagged myo1c (residues 721-1028); GFP-myo1c-tailIQ3, GFPtagged myo1c (residues 744-1028); GFP-myo1c-tailIQ0, GFP-tagged myo1c (residues
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768-1028); GFP-tail-K892A and GFP-tail-R903A, point mutations in GFP-myo1c-tail;
GFP-myo1c-K892A and GFP-myo1c-K903A, point mutations in GFP-myo1c.

Figure 11 Constructs

Figure 11: Domain structures of myo1c constructs
used in this thesis.
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2.3.2 DNA Handling

All DNA was amplified in competent DH5α cells. Cells were grown in 2xYT
media (171 mM NaCl, 16 g/mL tryptone, 10 g/mL yeast extract) in an orbital shaker
overnight at 37 °C, 250 RPM. Transformations were done by adding 0.5 µg DNA to 50
µL DH5α cells in a pre-chilled microcentrifuge tube and incubating on ice for 20
minutes. Reactions were heat pulsed at 42 °C for 45 seconds and placed on ice for 2
minutes. 500 µL of 2xYT was added to each tube and tubes were incubated at 37 °C for
1 hour with shaking at 250 rpm. Cells were placed on appropriate agar plates or
transferred to larger cultures containing either 100 µg/mL ampicillin or 30 µg/mL
kanamycin. DNA plasmids were purified using Promega Wizard Plus mini and midi
kits for 1.5 and 50 mL cultures respectively. DNA concentrations were calculated by
measuring absorbance in a UV-Vis spectrophotometer at 260nm, based on one A260
O.D. unit for dsDNA = 50 µg/ml.

2.3.3 Sequencing and Primers

All primers for DNA sequencing and point mutations were designed by hand
and ordered through Invitrogen (Life Technologies). DNA sequences were verified by
automated dideoxynucleotide sequencing at the University of Pennsylvania DNA
sequencing facility.
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2.3.4 Mutations

Point mutations in GFP-myo1c-tail (GFP-tail-R903A and GFP-tail-K896A) or
full length GFP-myo1c (GFP-myo1c-K892A and GFP-myo1c-R903A) were generated
using the Quick-Change Site-Directed Mutagenesis Kit according to the manufacturer’s
protocol (Stratagene Cloning Systems, La Jolla, California).

Forward and reverse

primers were designed containing single amino acid mutations to overlap desired sites
with melting temperatures over 78 °C. A thermo cycling reaction was performed for 16
cycles, followed by the addition of 10 U of DpnI and an hour incubation at 37 °C to
digest parent DNA. Each reaction was transformed into XL1-Blue cells and plated on
agar plates containing the appropriate antibiotic. Successful plates yielded, on average,
10-100 colonies. All point mutations were verified by automated dideoxynucleotide
sequencing.

2.4 Tissue Culture
2.4.1 Cell Types

We used a number of different mammalian cell types for the investigations in
this thesis. Normal rat kidney (NRK) epithelial cells were the primary cell type used for
our TIRF/FPAP experiments, as well as in many of our fluorescence imaging studies.
African green monkey kidney (COS-7) cells, Chinese hamster ovary (CHO) cells, and
HeLa cells were used in myo1c localization studies. Human embryonic kidney (293T)
cells were used primarily for small scale protein growths.
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2.4.2 Growth and Passaging

All cells types were grown in a 37 °C humidified incubator in 5% CO2. Cells
were maintained in growth medium, Dulbecco's Modification of Eagle's Medium
(DMEM) containing 10 % Fetal Bovine Serum (FBS), 100 U/ml penicillin, 100 µg/ml
streptomycin, and 0.25 µg/ml amphotericin B, in 10-cm round tissue culture plates.
Cells were passaged 1:10 using 0.25% trypsin-EDTA when 80-100% confluent, which
occurred in 2-4 days, depending on the cell type. Frozen, 1 mL aliquotted stocks in
DMEM with 15% FBS and 10% DMSO at 5x the normal passaging concentrations
were made for all cell types.

2.4.3 Transfections

NRK and COS-7 cells were transfected using transient electroporation.
Approximately five million cells were trypsinized from a 10-cm plate and resuspended
in 400 µL cold DMEM. 10 µg DNA was added and cells were transferred to a 0.4-cm
electroporation cuvette and incubated on ice for 5 minutes. Cells were electroporated in
a Bio Rad Gene Pulser II at 250 V, 950 µF for NRK cells, and 200 V, 950 µF for COS7 cells. Cells were immediately transferred to 60-mm plates with cover slips in 3 mL
growth media and incubated at 37 °C. Media was removed 4-6 hours later and cells
were incubated with fresh growth media overnight. To avoid apparent aggregation of
GFP-myo1c-tailIQ0, cells electroporated with this construct were grown overnight at 32
°C (Tang and Ostap 2001).
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HeLa, CHO, and 293T cells were transfected with Lipofectamine™ 2000. Cells
were grown in either 60-mm plates on top of cover slips or 15-cm plates until 95%
confluent at time of transfection. For a 60-mm plate, 8 µg DNA in 0.5 mL DMEM was
mixed with 10 µL Lipofectamine™ 2000 diluted in 0.5 mL DMEM and incubated for
20 minutes at room temperature.

For 15-cm plates, all reagents were scaled up

according to surface area. The DNA and Lipofectamine™ 2000 complex was added to
the cells and incubated overnight at 37 °C.

2.4.4 Fixing and Mounting Slides

To

fix

and

mount

cells

for

viewing

with

immunostaining

or

rhodamine/phalloidin, a 4% paraformaldehyde fixative was added to cells adhered to a
cover slip for 15 minutes. Cells were washed with PBS and permeablized in a 0.1%
Igepal solution for 10 minutes, then washed with PBS and blocked in a 1% BSA
solution with or without 1:1000 dilution of rhodoamine/phalloidin for 30 minutes. Cells
were then placed in permeablization buffer with 10 µg/mL primary antibody and
incubated for 1 hour, and washed and incubated in 1:500 dilution of secondary antibody
in permeablization buffer for 1 hour. Mounting solution was made by combining 120
µL of 0.017 g PPD, 1.5 mL 7.5% NaHCO3, 0.3 mL 0.5 M Na2CO3 with 100 µL of 10x
PBS + 780 µL 50% glycerol and pipetting 12 µL onto a clean slide. Cover slips were
lowered onto slides with mounting solution and sealed on all sides with red nail polish.
Before use, all antibodies were spun down at maximum speed in a microcentrifuge tube
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centrifuge for 5 minutes at 4°C to remove particulates. All solutions were made up in a
PBS solution containing Ca2+ and Mg2+.

2.5 Protein Detection
2.5.1 Determining Protein Concentration

All protein concentrations were determined with the Bradford assay using
Coomassie Plus (Pierce). Five standards were made containing 0, 2.5, 5, 10, and 20 ng
BSA in 95 µL total volume. 5 µL of protein buffer was added to each tube. Samples
were then made up by adding 5 µL protein to 95 µL H2O in duplicate. After adding 1.5
mL of Coomassie Plus, each tube was vortexed for 5 seconds. Absorbance at 595 nm
was measured using a UV-visible spectrophotometer. Standards were fit to a linear line
and that line was used to determine protein concentration.

2.5.2 Western Blots

For detection of proteins by Western blot analysis, proteins were run on an SDSPAGE gel and then transferred to a Hybond-C Extra nitrocellulose membrane
(Amersham Biosciences) in Towbin buffer (25 mM Tris, 192 mM glycine, 10%
methanol, 0.1% SDS) for 1 hour at 100 mV. The membrane was subjected to a series of
three 60 minute agitated incubations in blocking buffer, which was comprised of a 5%
milk solution in wash buffer (50 mM Tris, 150 mM NaCl, 0.05% Igepal, pH 8.0),
primary IgG antibody, and horseradish peroxidase linked ECL secondary-antibody IgG
(Amersham Biosciences). All antibodies were diluted in blocking buffer and thorough
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washings were done between each incubation. Following incubations, the membrane
was incubated in Super Signal West Pico chemiluminescent substrate (Pierce) for 5
minutes and then either placed in a developing cartridge and exposed to Kodak Blue
XB-1 film, or imaged using a gel scanner.

2.5.3 SYPRO® Red

For quantitative analysis of nanogram levels of proteins run on gels, we used
SYPRO® Red protein gel stain. Proteins were run on an SDS-PAGE gel and agitated
with SYPRO diluted 1:5000 in 7.5% acetic acid for 50 minutes. Gels were destained in
7.5% acetic acid for 10 minutes before being imaged on a gel scanner.

2.6 Protein Purification
2.6.1 Mouse Myo1c-Tail

The mouse myo1c-tail (accession # NM_008659) construct (residues 690 –
1028), which consists of an N-terminal HIS6 tag for purification, three CaM-binding IQ
motifs, and the tail domain, was expressed and purified from Sf9 cells as reported
(Tang, Lin et al. 2002). Myo1c-tail with bound CaM was purified from Sf9 cells that
were co-infected with virus-containing recombinant myo1c-tail and CaM. Four liters of
cells were suspended in 300 mL of 25 mM Tris, pH 7.5, 20 mM imidazole, 300 mM
NaCl, 0.5% Igepal, 0.5 mM EGTA, 1 mM 2-mercaptoethanol, 1 mM PMSF,
0.01 mg/mL aprotinin, and 0.01 mg/mL leupeptin at 4 °C and homogenized with five
strokes in a Dounce homogenizer. Cell extract was centrifuged at 100,000 × g for 1 h.
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The supernatant was sonicated five times for 15 s, incubated with 10 µg/ml RNase A
and 5 µg/ml DNase I on ice for 15 min, and loaded on to two 2 mL nickelnitrilotriacetic acid (Qiagen) columns. The columns were washed with five column
volumes of the same buffer without Igepal. Myo1c-tail was eluted with 5 ml of 125 mM
imidazole, 300 mM NaCl, 25 mM Tris pH 8.0, 0.5 mM EGTA, 1 mM 2mercaptoethanol, 0.01 mg/ml aprotinin, 0.01 mg/ml leupeptin, and 5 µM CaM from
each column. The elutions were diluted in 30 ml of 10 mM HEPES pH 7.0, 200 mM
NaCl, 1 mM EGTA, and 1 mM 2-mercaptoethanol and loaded on to a MonoS column
(Amersham Biosciences) equilibrated in 10 mM HEPES, 50 mM NaCl, 1 mM EGTA,
and 1 mM DTT. Myo1c-tail was separated and eluted with a linear 50 mM - 1 M NaCl
gradient. Myo1c-tail with bound CaM elutes at ~ 400 mM NaCl. Fractions containing
myo1c-tail were combined and dialyzed versus 10 mM Tris, pH 8.0, 50 mM NaCl,
1 mM EGTA, and 1 mM DTT and loaded on to MonoQ column (Amersham
Biosciences) equilibrated in 10 mM Tris, pH 8.0, 50 mM NaCl, 1mM EGTA, and 1 mM
DTT. Myo1c-tail was eluted with a linear 50 mM - 1 M NaCl gradient. Myo1c-tail
with bound CaM elutes at ~ 380 mM NaCl. Fractions containing myo1c-tail were
combined and concentrated to approximately 1.5 mL using Microsep concentrators (Pall
Filtron) or Ultra-15 Centrifugal Filter Units (Amicon). The concentrated protein was
dialyzed versus HNa100 overnight. Myo1c-tail concentrations were determined using
Coomassie Plus as described above. A typical yield of myo1c-tail with bound CaM
from 4 liters of cells was ~1 mg. The purified myo1c-tail contains three bound CaM. A
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typical gel showing various stages of the myo1c-tail purification is shown from Tang et
al. 2002 (Figure 12).

Figure 12 Purification of myo1c-tail

Figure 12: A Coomassie-stained SDS-PAGE gel of the purification of myo1ctail from (Tang, Lin et al. 2002). Lane 1) nickel-nitrilotriacetic acid column
elution.

Lanes 2) mono-S elution, and 3) mono-Q elution. Arrows specify

location of molecular mass markers. The calculated molecular mass of myo1ctail is 39 kDa.
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2.6.2 Mouse Myo1c-Motor

The myo1c-motor construct (accession # NM_008659) includes the motor
domain and 3 IQ motifs (residues 1 - 767). A 15 amino acid sequence for site-specific
biotinylation (Schatz 1993) and a FLAG sequence for purification were inserted at the
C terminus. Myo1c-motor was expressed and purified from Sf9 cells that were coinfected with virus containing recombinant myo1c-motor and CaM (El Mezgueldi,
Tang et al. 2002). Four liters of cells were suspended in 250 mL of 10 mM Tris, pH
7.5, 200 mM NaCl, 4 mM MgCl2, 2 mM ATP, 5 mM DTT, 0.5% Igepal, 1 mM EGTA,
1 mM PMSF, 0.01 mg/ml aprotinin, and 0.01 mg/ml leupeptin at 4 °C and homogenized
with five strokes in a Dounce homogenizer. Cell extract was centrifuged at 100,000 × g
for 1 h. Supernatant was loaded onto two 1.5 mL FLAG resin columns. The columns
were washed with five column volumes of the same buffer without Igepal, then two
column volumes of buffer without Igepal or ATP. Myo1c-motor was eluted with 5 ml
of 100 mM NaCl, 10 mM Tris, pH 8.0, 1 mM EGTA, 1 mM DTT, 0.01 mg/ml
aprotinin, 0.01 mg/ml leupeptin, 0.2 mg/mL FLAG peptide, and 5 µM CaM from each
column. Eluted protein was loaded on to a MonoQ column (Amersham Biosciences)
equilibrated in 10 mM Tris, pH 8.0, 50 mM NaCl, 1mM EGTA, and 1 mM DTT.
Myo1c-motor was eluted with a linear 50 mM - 1 M NaCl gradient. Myo1c-motor with
bound CaM eluted at ~ 430 mM NaCl.

Fractions containing myo1c-motor were

combined and dialyzed versus 50% glycerol, 50% HNa100.

Myo1c-motor

concentrations were determined using Coomassie Plus as described above. A typical
yield of myo1c-motor with bound CaM from 4 L of cells was ~2 mg. The purified
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myo1c-motor contained three bound CaM. A typical gel showing various stages of the
myo1c-motor purification is shown (Figure 13).

Figure 13 Purification of myo1c-motor

Figure 13: A Coomassie-stained SDS-PAGE gel of the purification of
myo1c- motor. Lanes 1-4) Elutions from FLAG resin column. Lanes
5-14) Elutions from Mono-Q column. Arrows specify location of
molecular mass markers. The calculated molecular mass of myo1cmotor is 89 kDa.
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2.6.3 Calmodulin (CaM)

Recombinant chicken CaM was expressed and purified from bacterial lysates
using a phenyl sepharose column in the presence of EDTA, and then CaCl 2 (Putkey,
Slaughter et al. 1985), and further purified by FPLC using a MonoQ column
(Amersham Biosciences).

This final MonoQ step was crucial, since we found a

bacterial contaminant present in very low abundance (Figure 14) that effectively
competed with myo1c-tail for binding to anionic lipids (Hokanson and Ostap 2006).
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Figure 14 Purification of CaM

Figure 14: A SYPRO red-stained SDS-PAGE gel of pellet samples from a
sedimentation assay of CaM with 60% PS LUVs. Lane 1) 60% PS LUVs control.
Lanes 2-3) 60% PS LUVs with CaM, 50 and 100 µM. Lanes 4-5) 60% PS LUVs
with CaM, 50 and 100 µM, after purification with Mono-Q.

Note the high

molecular weight contaminants in lanes 2-3. Arrows specify location of molecular
mass markers. The calculated molecular mass of CaM is 16 kDa.
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2.6.4 Glutathione-S-Transferase (GST)

GST was used to block non-specific interactions and was purified from BL21pLys cells. BL21-pLys cells were transfected with a pGEX.B23 vector containing
GST. Cell cultures of 2.5 L were grown containing 100 µg/mL ampicillin and 34
µg/mL chloramphenacol and induced with 1 mM IPTG for 3 hours after cells reached
an OD of 0.7 at 600 nm. Cells were harvested by centrifugation for 20 minutes at
10,500 x g. The pellet was resuspended in 100 mM NaCl and spun at 5000 x g in a 50
mL conical tube for 15 minutes. The pellet was then flash frozen in liquid N2 and
stored at -80 ºC. The frozen cell pellet was resuspended in 50 mL of PBS (1.4 mM
NaCl, 27 mM KCl, 101 mM Na2HPO4, 18 mM KH2PO4), 1 mM DTT, 1 mM PMSF,
and 1% triton at 4 °C.

The lysate was sonicated for 15 seconds five times and

centrifuged for 30 minutes at 27,000 x g. The supernatant was loaded onto a 2.5 mL
Glutathione Sepharose 4B matrix column immediately after the spin and washed with
five column volumes of PBS with 1 mM DTT. GST was eluted with two column
volumes of reduced glutathione buffer (10 mM glutathione, 50 mM Tris, pH 8.0). 2.5
mL of bacterial cells typically yielded ~ 100 mg GST. A typical gel showing various
stages of the GST purification is shown (Figure 15).
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Figure 15 Purification of GST

Figure 15: A Coomassie-stained SDS-PAGE gel of the purification of
GST.

Lane 1) Lysis from BL21 cells.

Lane 2) Supernatant from

sedimentation. Lane 3) Wash from glutathione sepharose column. Lane 4)
Elution from glutathione sepharose column. Lane 5) Blank. Lane 6) 100 x
dilution of elution from glutathione sepharose column. Arrows specify
location of molecular mass markers. The calculated molecular mass of
GST is 29 kDa.
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2.6.5 Fibrinogen

Lyophilized fibrinogen was a gift from Dr. Paul Janmey (University of
Pennsylvania) and was rehydrolyzed in HNa100, aliquotted into 1 mL samples, frozen
in liquid N2, and stored at -80 ºC. The final concentration for fibrinogen was ~8 mg/mL
with 3% fibronectin present.

2.6.6 Phospholipase-Cδ Pleckstrin Homology Domain (PLCδ-PH)

A bacterial expression plasmid for the PH domain of phospholipase-Cδ
(residues 11 – 140; PLC-PH) was a gift from Dr. Mark Lemmon (University of
Pennsylvania) and was purified as described (Ferguson, Lemmon et al. 1994). BL21
(DE3) RP cells were transfected with a pGEX.B23 vector containing PLC-PH. Cells
were grown in 4 L cultures containing 100 µg/mL ampicillin and 34 µg/mL
chloramphenacol and induced with 1 mM IPTG for 3 hours when cells reached an OD
of 0.7 at 600 nm. Cells were harvested by centrifugation for 20 minutes at 10,500 x g,
and the pellet was resuspended in 100 mM NaCl and spun at 5000 x g in a 50 mL
conical tube for 15 minutes. The pellet was frozen in liquid N2 and stored at -80 ºC.
Upon removal from storage, the pellet was resuspended in 50 mL 100 mM NaCl, 50
mM glucose, 25 mM MES, pH 6.0, 5 mM DTT, and 1 mM PMSF. The lysate was
sonicated five times for 15 s and centrifuged for 30 minutes at 27,000 x g.

The

supernatant was loaded onto a pre-equilibrated 60 mL DEAE cellulose column and
washed with two column volumes of 25 mM MES pH 6.0, 50 mM NaCl, 1 mM DTT,
and 1 mM PMSF. All flow through was collected and diluted 3-fold with 25 mM MES
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pH 6.0, and 1 mM DTT and then loaded directly onto a pre-equilibrated S-sepharose
column. The S-sepharose column was washed with two column volumes of 25 mM
MES, pH 6.0, and 1 mM DTT, and then the protein was eluted in 6 mL fractions with a
250 mL linear salt gradient from 0-500 mM NaCl. The protein eluted from this column
at ~ 120 mM NaCl. Fractions containing PLC-PH, as determined by the OD at 280
nm and a SDS-PAGE gel, were pooled and ammonium precipitated to 75% saturation,
0.476 g/mL NH4SO4, overnight at 4 ºC. The precipitate was centrifuged at 17,000 x g
for 15 minutes and the pellet was resuspended in a minimal volume of 25 mM MES pH
6.0, 150 mM NaCl, and 1 mM DTT by gentle mixing. The protein was aliquotted into
microcentrifuge tubes and centrifuged at maximum speed for two minutes to pellet
particulates. The protein was syringe filtered through a 0.22 µm filter and loaded onto a
Superdex 200 gel filtration column. PLC-PH ran as a 20 kDa protein. The fractions
containing protein, as determined by SDS PAGE gel, were pooled together and dialyzed
overnight versus 2 L HNa100. The protein solution was concentrated using Microsep
concentrators (Pall Filtron) and aliquotted into 50 µL samples that were frozen in liquid
N2 and stored at -80 ºC. A typical gel showing various stages of the purification of
PLC-PH is shown (Figure 16).
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Figure 16 Purification of PLCδ-PH

Figure 16: A Coomassie-stained SDS-PAGE gel of the purification of PLCδ-PH.
Lane 1) Supernatant of lysed cells. 2) Pellet of lysed cells. 3) Elution from DEAE
column.

4) Elution from S-Sepharose elution.

5) Elution from gel filtration

column.

Arrows specify location of molecular mass markers. Lanes are non-

continuous and are taken from 2 gels of the same protein preparation. Lanes from
elutions with little or no protein have been excluded. The calculated molecular
mass of PLCδ-PH is 20 kDa.
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2.6.7 GFP-Tagged Myo1c-Tail

Small amounts of GFP-tail, GFP-tail-K892A and GFP-tail-R903A were purified
for binding experiments by transient expression in HEK-293T cells (Hokanson, Laakso
et al. 2006).

Transfected cells (~1x109 cells per transfection) were collected by

sedimentation, flash frozen in liquid N2, and stored at -80 C. GFP-proteins were
purified in a 1-day procedure. Pellets of ~1x109 cells were suspended in 15 mL lysis
buffer (10 mM HEPES pH 7.0, 1 mM EGTA, 300 mM NaCl, 5mM DTT, 0.5% Igepal,
1mM PMSF, 0.01 mg/mL aprotinin, and 0.01 mg/mL leupeptin), lysed by 8 strokes in a
Dounce homogenizer, and centrifuged for 1 hour at 100,000 x g. The supernatant was
incubated on ice with 10 µg/mL RNase A and 5 µg/mL DNase I for 20 minutes. After
dilution, the final NaCl concentration of the supernatant was 100 mM; the supernatant
was then passed through a 0.22 µm syringe filter and loaded immediately onto a
MonoQ column (Amersham Biosciences). Protein was eluted from the MonoQ column
using a linear salt gradient, and GFP-proteins were detected by monitoring GFP
fluorescence.

Fractions containing GFP were diluted to 100 mM final NaCl

concentration, and CaCl2 was added to attain 1 mM free Ca2+. The protein was loaded
immediately back on the MonoQ column and eluted with a linear salt gradient in
column buffers containing 1 mM free Ca2+.

The addition of Ca2+ results in the

dissociation of a CaM from myo1c (Zhu, Beckingham et al. 1998; Sokac and Bement
2000). We found that this CaM dissociation causes the GFP-proteins to elute from the
MonoQ column at a lower salt concentration, resulting in their separation from Ca2+insensitive proteins. 5 µM CaM and 5 mM EGTA were immediately added to the
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eluted GFP-proteins, and the proteins were dialyzed overnight versus HNa100. GFPtail, GFP-tail-K892A, and GFP-tail-R903A were > 90% pure as determined by SYPROred staining of SDS-PAGE gels (Figure 17). GFP-proteins were stored on ice and used
in binding assays within 2 days of purification. Yields of pure GFP-proteins were low
(2 – 3 µg per transfection), but the preparations provided enough material to perform
binding assays. A Western blot analysis with anti-GFP is shown (Figure 17 inset).
293T cells transfected with GFP-myolc-tail were also lysed and purified in the
presence of phosphatase or phosphatase inhibitors. Phosphatase inhibitor was added to
293T cells during pellet resuspension and lysis. Cells lysates were then separated into
two fractions; 400 U/µL of lambda protein phosphatase was added to one, then both
fractions were purified separately as described above.

Figure 17: A SYPRO-red stained
SDS-PAGE gel showing purified
GFP-tail constructs.

Lane 1) GFP-

tail. Lane 2) GFP-tail-R903A. Lane
3)

GFP-tail-K892A.

Bottom)

Western blot of purified GFP-myo1ctail constructs stained with anti-GFP
antibody. Figure originally published
in (Hokanson, Laakso et al. 2006).
Figure 17 Purification of GFP-tail constructs
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2.6.8 Mouse Myo1c-Tail Monoclonal Antibody (M2)

Frozen hybridoma cells containing a monoclonal antibody for the epitope
PVVKYDRKGYKPRPRQLLL in mouse myo1c (M2), a gift from Peter Gillespie
(Oregon Health and Science University, Portland, Oregon), were rapidly thawed and
transferred to 5 mL warm RPMI 1640 medium containing 10% FBS and 1:100
penicillin and streptavidin. Cells were started in a 6-cm tissue culture plate and split 1:5
into larger volume plates each time cell densities reached 1 million cells/mL until cell
volume reached 0.5 L. Supernatant was collected by centrifuging cells at 2500 x g for 5
minutes at 4 °C. The supernatant was filtered through a 0.22 µm filter and loaded onto
a pre-equilibrated 1 mL HiTrap Protein G HP column (GE healthcare) at 4 °C. The
HiTrap column was washed with 20 mL PBS and the protein was eluted with 5 mL 100
mM glycine pH 2.5 into 0.5 mL fractions containing 25 µL 1 M Tris pH 9.5 to
neutralize the pH. Fractions were run on an SDS-PAGE gel; those containing antibody,
with bands appearing at 30 and 50 kDa (Figure 18), were pooled and dialyzed verses 2
L PBS overnight, followed by 6 hours versus 500 mL 50% PBS, 50% glycerol.
Supernatants collected from a 500 mL preparation yielded ~ 1.5 mg antibody.
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Figure 18 Purification of M2 antibody

Figure 18: A Coomassie-stained SDS-PAGE gel of the purification
of M2. Lanes 1-7) Elutions of HiTrap column. Arrows specify
location of molecular mass markers. The calculated molecular mass
of the light and heavy chain subunits of an antibody are ~30 and
50 kDa.
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2.7 Assays
2.7.1 Lipid Preparation

Lipid components were mixed in the desired ratios in chloroform and dried
under a stream of nitrogen. Phospholipid vesicles containing PIP2 were also prepared
by first placing the methanol/water/chloroform solution in a 35 C water bath for five
minutes and then applying maximum vacuum in a rotovap for 30 minutes to ensure
uniform inclusion of PIP2 and PC (Gambhir, Hangyas-Mihalyne et al. 2004). This
method was used to ensure that all of the chloroform was removed from the lipid
samples; however, we found that LUVs formed using either of these two methods were
identical, and therefore, we primarily prepared LUVs using a stream of N2 gas.

2.7.2 Sucrose-Loaded LUVs

Large unilamellar vesicles (LUVs) with 100 nm diameter were prepared by
extrusion (Hokanson and Ostap 2006). Lipids to be used in sedimentation experiments
were resuspended in 176 mM sucrose, 12 mM HEPES pH 7.0, to a total concentration
of 1 or 2 mM. This solution was used to increase the density of the LUVs so they
would form a pellet in our sedimentation assays while maintaining the same osmolarity
as our HNa100 buffer. Five cycles of rapid freeze-thaw using ethanol/dry-ice and a 37
°C water bath, followed by a one minute incubation in a bath sonicator, were applied
before passing each lipid solution through a 100-nm filter (11 times) using a miniextruder (Avanti Polar Lipids). LUVs were dialyzed overnight versus HNa100. LUVs
were stored at 4C under N2 gas and discarded after 3 days. PS and PIP 2 percentages
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reported throughout the text are the mole percentages of total PS and PIP2 in a
background of PC. Lipid concentrations are given as total lipid unless otherwise noted.
We checked that the diameter of our LUVs were uniformly 100 nm, by using
dynamic light scattering (DLS) to measure the dispersion of sizes. LUVs were
consistently found to be 100 nm in diameter with very little dispersion. We did find that
under high divalent cation levels, such as Ca2+, the dispersion of LUV sizes tended to
increase as well as the average size of LUVs (Figure 19) due to a known effect of Ca2+
to the lipid vesicle structure (Bentz and Duzgunes 1985).
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Figure 19 Ca effect on DLS of LUVs

Figure 19: A histograph of the distribution of LUVs by DLS.
Size distribution of 2% PIP2 LUVs with 0 mM (black bars), 10
µM (hashed bars), or 100 µM Ca2+ (open bars) by DLS.
Frequency of radii from 28 scans per each sample is shown.
Note that the addition of Ca2+ causes the size distribution to
shift to the right and become more dispersed.
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2.7.3 Phosphorous Assay

To check that the concentrations of LUVs we were calculating were correct, we
determined the total amount of phosphorous in a typical LUV sample following a
modified procedure of Fiske & Subbarow from Avanti Polar Lipids (Fiske and
Subbarow 1925). We used 0 - 0.0456 µmoles KH2PO4 to make phosphorous standards
along with our samples of LUVs made up of various lipids. Solvent was removed with
a stream of N2 and 90 µL of 8.9 N H2SO4 was added to each tube. All samples were
heated to 210 ºC in an aluminum heating block for 25 minutes. Tubes were removed
and left to cool for 5 minutes before adding 30 µL of H2O2. Tubes were reheated at 210
ºC for 30 minutes, then allowed to cool to ambient temperature before adding 780 µL of
H2O. We then added 100 µL of 2.5% ammonium molybdate tetrahydrate solution and
again vortexed each tube five times. We next added 100 µL of 10% ascorbic acid and
vortexed each tube five times. A marble was placed over each tube to minimize
evaporation and tubes were heated to 100 ºC for seven minutes.

Absorbance of

standards was measured at 820 nm using a UV/Visible spectrophotometer and used to
generate a linear calibration curve to determine the concentration of phosphorous in
each LUV sample. Predicted concentrations of LUVs were found to be accurate within
5%.
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2.7.4 Sedimentation Assay

To test the binding of myo1c-tail to LUVs, we sedimented LUVs in a TLA100
rotor (Beckman), with a rave of 3.45 cm at 63,000 rpm to produce forces of 150,000 x g
according to:
Equation 1

𝑔𝑐𝑒𝑛 =

(𝜔)2 𝑟
𝑔

where ω is the angular velocity in revolutions per second, r is the average radius of the
rotor, and g is a gravitational constant of 980 cm/s2.

2.7.4.1 Defining Pellet

We determined that sucrose loaded LUVs sedimented to the bottom 10% of a
centrifuge tube when centrifuged at 150,000 x g after 20 minutes, but that they do not
form a stable pellet. 200 µL samples of LUVs made with 5% dansyl labeled PS were
centrifuged at 150,000 x g for 30 minutes. Five samples at sequential depths were
carefully extracted from each centrifuge tube. We checked the samples for fluorescence
at 340:500-620 nm and found that no lipid was found in the top 90% of the tube, but
~100% of the expected lipid was found in the bottom 10% (Figure 20). Following
removal of the supernatant, HNa100 was added to the tubes to suspend any pellet; no
florescence was found in this sample. This experiment was repeated with LUVs that
did not contain dansyl labeled lipids, but were monitored by total phosphorous as
described above; the results were identical. We thus define the “pellet” as the bottom
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20% of the sample in a centrifuge tube after a 30 minute spin at 150,000 x g for all of
our sedimentation assays.

Figure 20 Sedimentation assay pellet

Figure 20: Quantification of the fluorescence of the lipid gradient of
sucrose-loaded LUVs after centrifugation. A 500 µL sample of LUVs
containing 5% dansyl-labeled PS was centrifuged at 150,000 x g for
30 min. Successive aliquots of the supernatant were removed and
analyzed for fluorescence at 340:500-620 nm.

After removal of

supernatant, 40 µL HNa100 was added to centrifuge tube and analyzed
as pellet.
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2.7.4.2 Nonspecific Interactions

Nonspecific interactions between our protein and the walls of the polycarbonate
centrifuge tubes caused a significant loss of protein, which was a concern since our
experiments used protein concentrations of 40 nM to stay well below the Kd of binding.
Nonspecific binding is thought to be due to the highly basic charge interaction with the
acidic polycarbonate. Without protection, the myo1c-tail would practically disappear,
as assessed by SDS-PAGE gel.
Two different strategies were combined to solve this problem. All tubes were
coated with a bath sonicated solution of 40 µM PC hydrated in HNa100. This formed a
thin film on the polycarbonate, which prevented myo1c from binding. The addition of
non-specific blocking proteins to the samples was also used to help resolve this issue.
Three different proteins were tested; CaM, fibrinogen, and GST (Figure 21). CaM
showed no increase in recovery of myo1c from polycarbonate tubes; fibrinogen and
GST both showed close to 100 % recovery. We selected GST because of its low
molecular weight and availability, and added 0.25 mg/mL to all centrifugation samples.
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Figure 21 Nonspecific blockers

Figure 21: Quantification of the recovery of myo1c-tail after sedimentation in
the presence of proteins to block nonspecific interactions to the polycarbonate
tubes. CaM, Fibrinogen, or GST (5 mg/mL) were added to 40 nM myo1c-tail
and centrifuged at 150,000 x g for 30 minutes. Samples were analyzed for the
percentage of myo1c-tail recovered from supernatant after centrifugation.
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2.7.4.3 Sedimentation

Protein binding to LUVs was determined by sedimentation assays conducted
with 200 l samples in an ultracentrifuge with a TLA-100 rotor (Beckman).
Polycarbonate centrifuge tubes were incubated for an hour in 50 μM solution of PC in
HNa100. GST (0.25 mg/ml) was added to every sample. Sucrose-loaded LUVs were
sedimented at 150,000 x g for 30 min at 25 C. The top 160 L of each sample was
removed and analyzed as supernatant. We called the remaining 40 μL the “pellet,”
although it contains approximately 20 % of the supernatant. The pellets were resuspended with 10 L SDS-PAGE sample buffer and boiled for three minutes. Bound
proteins were resolved by SDS-PAGE and stained with SYPRO-red (Invitrogen) for
quantization as described below. A sample gel with standards is shown (Figure 22).
Supernatants containing GFP-proteins were assayed for GFP fluorescence in a
fluorimeter. Gels were scanned using a gel scanner, and data were analyzed with
MetaMorph (Universal Imaging).
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Figure 22 Sedimentation assay

Figure 22: A representative SYPRO red stained SDS-PAGE gel from a
sedimentation assay. Top) Approximate scale representation of a 100 nm
LUV and a full length myo1c binding. Bottom) SYPRO-red stained SDSpolyacrylamide gel of myo1c-tail from the pellets of a sedimentation assay
with 0 - 400 M LUVs (total lipid) containing 2% PIP2. The last 3 lanes are
myo1c-tail standards used for normalization.
published in (Hokanson and Ostap 2006)
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Bottom figure originally

2.7.5 Gel Filtration

Gel filtration allows for the separation of molecules based on hydrodynamic
radius. Columns are made up of beads with small pores that increase the run volume of
smaller molecules, while proteins too large to fit in the pores flow by in a smaller run
volume. Therefore, a column containing beads with pore sizes that are relative in size
to the hydrodynamic radii of the small molecules of interest can be used to test for the
direct binding of these small molecules to larger proteins. The population of small
molecules bound to the larger proteins will elute much earlier than the population of
free small molecules. To separate free Ins(1,4,5)P3 from myo1c-tail bound Ins(1,4,5)P3,
we initially tried Sephadex G-25 resin, but found that the myo1c-tail bound to the resin
through presumably nonspecific interactions. Therefore, we used ToyoPearl HW40F
resin, which did not interact with myo1c-tail, but did retard the elution of free
Ins(1,4,5)P3.
Gel filtration assays were preformed as described (Lemmon, Ferguson et al.
1995). ToyoPearl HW40F resin (10 mL) was resuspended and packed into a 9 mm
diameter column. The gel filtration column was equilibrated with 10 column volumes
HNa100; protein samples of 50 µL PLC-PH (10 μM) or 10 μM myolc-tail mixed with
2-fold excess 3H-Ins(1,4,5,)P3 in HNa100 buffer were carefully loaded onto the top of
the column bed without disturbing the resin. After the protein and Ins(1,4,5)P3 mixture
was fully immersed into the column bed, HNa100 was added to the column in 3 x 100
µL aliquots and then used to fill the column. Fractions were collected every ~200 L
starting as soon as the protein and Ins(1,4,5)P3 mixture was loaded onto the column.
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The elution position of protein was determined by absorbance at 280 nm. Scintillation
counting was used to detect the 3H-Ins(1,4,5)P3 elution position by measuring the
counts per minute of 50 µL of each fraction in 5 mL of scintillation fluid.

2.7.6 Digestions

Trypsin was used to do controlled digests of myo1c-tail at various
concentrations and time points. Trypsin and soybean inhibitor (SI) were made up to 5
mg/mL stock solutions in HNa100. Trypsin was added in 1:100 to 1:2000 ratios by
weight to myo1c-tail plus or minus Ins(1,4,5)P3 and incubated for 0 to 40 minutes
before each reaction was quenched with SI. Samples were then run on an SDS-PAGE
gel and imaged by Coomassie staining or by Western blot.

2.7.7 Florescence Studies

Florescence resonance energy transfer (FRET) is a fluorescence technique that
measures the fluorescence resonance energy transfer of one fluorophore, a donor, to
another fluorophore, an acceptor, when the two fluorophores are in close proximity to
one another (Lankiewicz, Malicka et al. 1997). LUVs containing both BODIPY FLPIP2 and BODIPY TMR-PIP2 were used to detect the clustering of PIP2 upon protein
binding. These fluorescent tags were chemically attached to the acyl chains of PIP2 and
should not have affected the binding of proteins to the inositol head-group. We excited
our donor, fluorescein (FL), at 495 nm, which resulted in an emission spectrum that
overlapped with the excitation spectrum of our acceptor, tetramethylrhodamine (TMR).
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We measured the emission of any consequently excited TMR at 575 nm. Emission and
excitation spectra of the fluorophores are shown (Figure 23).

When the two

fluorophores are close enough to each other, the emission of the donor fluorophore is
transferred to the acceptor fluorophore. A decrease in the fluorescence of the donor and
an increase in the fluorescence of the acceptor were then seen as an increased number of
fluorophores were clustered together.

Thus, the fluorescence ratio of FL/TMR

decreased when the fluorescent PIP2 molecules were clustered together by the binding
of a protein (Figure 24).
LUVs with 0.4% BODIPY FL-PIP2 and 0.4% BODIPY TMR-PIP2 in a
background of PC were titrated with 0 – 1 µM myo1c-tail or MARCKS peptide (a gift
from Dr. Mark Lemmon). FRET from FL to TMR was detected by exciting FL at 500
nm and measuring TMR emission fluorescence at 575 nm.

Figure 23 Excitation and emission spectra of FL and TMR

Figure 23: The fluorescence excitation and emission scans of FL
and TMR labeled PIP2. FL excites at 505 nm and emits at 513 nm.
TMR excites at 532 nm and emits at 574 nm.
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Figure 24 FRET from clustering PIP2

Figure 24: A schematic of FRET. Upon excitation, yellow arrow, the
donor molecule, FL, becomes excited and emits light, orange arrow.
This emission either leaves the system (left) or is transferred to an
acceptor molecule, TMR (right). The latter is the case when the two
fluorophores are near each other as depicted on the right by the
presence of MARCKS.
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2.8 Live Cell Imaging
Cells were placed on 40-mm glass cover slips and mounted in a temperaturecontrolled flow chamber (Bioptechs, Butler, PA) for microscopic observation and
perfused with DMEM, 10 mM HEPES, and 10% FBS (Tang and Ostap 2001). Cells
were visualized through a 63x oil immersion objective with an inverted fluorescence
microscope (Leica). The temperature of the flow chamber and microscope objective
was maintained at 37 °C throughout the experiment. Images were acquired with a
digital camera (Hamamatsu) and Metamorph software (Universal Imaging).

The

fluorescence excitation light was shuttered (Sutter Instruments), and exposure times
were between 0.1 and 1.0 s.

2.8.1 TIRF/FRAP

TIRF is a technique designed to reduce background fluorescence of a specimen
by exciting fluorophores within 100 nm of the objective (Axelrod, Thompson et al.
1983). Evanescent waves that excite fluorophores are generated when an objective with
a high numerical aperture is used to bring incident light in at an angle larger than the
critical angle with respect to the surface, and is totally reflected at the glass-water
interface. The resulting evanescent electromagnetic field decays exponentially from the
interface, and thus penetrates to a depth of approximately 100 nm into the sample
medium. This technique allowed us to look at events that occurred at and directly
above the plasma membrane without the background fluorescence of the entire cytosol.
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2.8.1.1 TIRF

Objective-type total internal reflection fluorescence (TIRF) microscopy was
performed on a modified Leica DMIRB microscope fitted with a Nikon 1.45 NA
objective (Axelrod 2001).

Samples were illuminated through the rear port of the

microscope with a 488 nm laser beam (Melles Griot) focused on the back focal plane of
the objective.

Images were acquired with a digital camera (Hamamatsu) and

Metamorph software (Universal Imaging). A computer controlled filter wheel (Sutter
Instruments) containing neutral density filters was placed in the beam path to allow for
attenuation of the beam.

2.8.1.2 FRAP

We combined TIRF with fluorescence recovery after photobleaching (FRAP) to
measure dissociation rates of membrane bound myo1c. We were able to bleach either
an entire cell or a ~ 10 µm spot on a cell expressing GFP-tagged constructs and
measured the recovery of fluorescence over time. The recovery of fluorescence was
due to new, unbleached fluorophores replacing bleached fluorophores at either the
membrane, or diffusing in the cytosol just above the membrane. Since the association
of myo1c to the membrane was measured to be diffusion limited (Tang, Lin et al. 2002),
we were able to interpret the recovery of fluorescence as dissociation rates of bleached
protein. Photobleaching by TIRF illumination was accomplished by removing the
neutral density filter and decreasing the beam diameter.
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TIRF/FRAP was performed as follows. Five prebleached TIRF images were
acquired 5 - 10 s apart with a 100 ms acquisition time, followed by a 1 s bleaching
TIRF pulse, followed by the immediate acquisition of images 1 - 2.5 s apart with 100
ms acquisition time.

The bleach illumination was 10 - 100-fold more intense

(depending on the cell intensity) than the imaging illumination.

2.9 Data Analysis
2.9.1 Binding Data Analysis

To quantify the amount of protein in each lane from our sedimentation binding
assays, the integrated intensity of each protein band on the scanned gels was subtracted
from the integrated intensity of the region directly above the protein band to correct for
variations in background. Protein standards of known concentration were run on each
gel to ensure that the intensity of the protein bands were within the linear range of the
scanner and to translate integrated intensity to moles of bound protein (Figure 22). We
reported the binding affinity of myo1c protein constructs to LUVs as a molar partition
coefficient in terms of total lipid concentration (Kefflipid) or in terms of the accessible
acidic phospholipid concentration (Keffacidic).

The molar partition coefficient, K, is

defined by:
Equation 2

[𝑃]𝑚
= 𝐾[𝑃]
[𝐿]
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where [P]m is the molar concentration of the protein bound to the membrane, [P] is the
free protein concentration, and [L] is the total lipid concentration (Peitzsch and
McLaughlin 1993). In our experiments [L] is in 1000-fold excess to [P]m so loss of [L]
after binding does not need to be considered. By defining [P]tot:
Equation 3

𝑃

𝑡𝑜𝑡

= 𝑃

𝑚

+ 𝑃

binding curves can be fit to:
Equation 4

[𝑃]𝑚
𝐾[𝐿]
=
[𝑃]𝑡𝑜𝑡 1 + 𝐾[𝐿]
where K equals the concentration of lipid at which half of the protein binds and is given
in M-1. Binding data were fit to hyperbolae using KaleidaGraph.
All data were normalized from integrated intensities to molar concentrations by
fitting internal standards of known myo1c-tail concentration from each gel to a linear
line. Data was further normalized to percentage of myo1c-tail bound by:
Equation 5

%𝐵𝑜𝑢𝑛𝑑 =

[𝑀𝑥 ] − [𝑀0 ]
[𝑀𝑡 ] − [𝑀0 ]

where Mx is the concentration of myo1c-tail in the pellet in the presence of x lipid, M0 is
the concentration of myo1c-tail in the pellet in the absence of lipid, and Mt is the
concentration of myo1c-tail calculated if 100% of it was in the pellet.
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Binding data plotted as a function of [NaCl] were fit to an abbreviated equation
derived from Debye-Hückel theory that describes the change in dissociation constant
with ionic strength by:
Equation 6

𝑙𝑜𝑔𝐾 = 𝑙𝑜𝑔𝐾0 −

2𝐴𝑧𝑅 𝑧𝐿 𝐼
1 + 𝑟𝐵 𝐼

where logK is the log of the dissociation constant, A and B are thermodynamic constants
equal to 0.509 and 2.391 nm-1 respectively, zR and zL are the charges on the receptor and
ligand respectively, I is the ionic strength , and r is the effective interaction distance
between receptor and ligand (Meltzer, Lurtz et al. 2006). Ionic strength is defined by:
Equation 7

𝐼=

1
2

𝑖

𝑚𝑖 𝑧𝑖2

where m is the molar concentration of the ion, and z is the charge.

2.9.2 Competition Data Analysis

Soluble inositol phosphate competition data were fit to:
Equation 8

𝑓𝑏 =

𝑎𝑐𝑖𝑑𝑖𝑐
𝐾𝑒𝑓𝑓

[𝑃𝐼𝑃2 ]
𝐼𝑛𝑠𝑃
1+ 𝐾 𝑥
𝐼𝑛𝑠𝑃𝑥

+ [𝑃𝐼𝑃2 ]

where [PIP2] is the concentration of accessible PIP2, [InsPx] is the concentration of the
soluble inositol phosphate, KInsPx is the affinity of the inositol phosphate for myo1c, and
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Keffacidic is the effective dissociation constant of the myo1c-PIP2 interaction in terms of
accessible concentration of PIP2 (Kubala, Plasek et al. 2004).

2.9.3 TIRF/FRAP Analysis

For presentational purposes, the photobleached region of each cell was
normalized by dividing the image by the same region acquired 20 – 30 s before the
bleach pulse, and then multiplied by 1000 to allow visualization of a 12-bit image. This
normalization allows the fluorescence recovery to be visualized without the
complication of cell intensity variation.
For analysis, the average background intensity was subtracted from the image,
and the integrated intensity of the bleached spot was normalized by dividing by the
intensity before the bleach. Thus, the intensity of the spot before the bleach is set to
one, and absence of fluorescence is set to zero.

After the bleaching pulse, the

illumination required for visualization of the recovery time-course resulted in further
photobleaching (< 15%) in some cells. This non-FRAP bleaching was corrected for by
subtracting the rate of photobleaching as determined in an area away from the FRAP
region.

The effective rate of fluorescence recovery was determined by fitting the

recovery transient to the sum of two exponential rates using KaleidaGraph (Synergy
Software).
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2.10 Molecular Modeling and Structure Prediction
2.10.1 Phyre Protein Fold Recognition Server

We used the Phyre server (www.sbg.bio.ic.ac.uk/phyre/) to initially reveal the
secondary structural similarities of the tail domain to a PH domain. The Phyre server
predicts the three-dimensional structure of a protein sequence by “threading” it through
known structures and scoring it for compatibility (Kelley, MacCallum et al. 2000). To
identify potential structural homologs, we performed a BLAST search on the myo1c-tail
sequence, identifying phosphatidylinositol-dependent protein kinase-1 (PDK1) as a
limited sequence match.

Since PH domain of Pdk1 had been crystallized with

Ins(1,3,4,5)P4 (PDB 1W1D) and our myo1c-tail sequence showed 61% identity over the
PIP2 binding region of PDK1, we used this structure for a detailed structural
comparison.

2.10.2 Ab Initio Structural Prediction

To provide further speculative structural insight into the binding of PIP2 by the
myo1c- tail, we collaborated with Dr. Dave Sept (Washington University, St. Louis,
MO) who ran the mouse myo1c sequence through Pfam to identify known domains
(Bateman, Coin et al. 2004).

Based on the Pfam analysis, he selected a region

following the IQ motif as the tail region (P802-R1028) and used this sequence in ab
initio structure prediction with Rosetta (Bonneau, Strauss et al. 2002), generating a total
of 50 structures.

Clustering the structural predictions based on root mean square

deviation resulted in a top structural candidate, and the side-chains of this structure were
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added in and minimized using PLOP (Jacobson, Pincus et al. 2004).

This completed

structure was then simulated using molecular dynamics in Gromacs 3.3 (Lindahl 2001).
The simulation used the OPLS/AA force field, TIP3P water, and periodic boundary
conditions with Particle Mesh Ewald for long range electrostatics. After heating the
system in 50K steps and equilibrating for 1 ns, the structure was simulated for a total of
20 ns at 300K.

There were some minimal structural rearrangements during the

simulation, but the basic structure of the protein remained constant throughout the
simulation. Finally, to identify potential structural homologs, we performed a BLAST
search on the myo1c-tail sequence, identifying phosphatidylinositol-dependent protein
kinase-1 (PDK) as a limited sequence match. Since PDK1 had been crystallized with
Ins(1,3,4,5)P4 (PDB 1W1D) and our myo1c tail sequence showed 61% identity over the
PIP2 binding region of PDK1, we used this structure for a detailed structural
comparison.
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3 Results
In this section, data will be presented from an investigation into the interactions
of myo1c with the lipid membrane. In this study, sedimentation assays were used to
characterize the binding constants of myo1c for LUVs composed of various ratios of PS
and PIP2, as well as inositol phosphates. Constructs defined in chapter two were
expressed in NRK cells to determine localization and in vivo activity. These results
reveal that myo1c binds tightly to PIP2 through a specific interaction in its tail domain.

3.1 Mechanism for Membrane Binding
To understand biochemically how myosin-Is interacted with the plasma
membrane, we obtained steady state binding constants by performing a quantitative
investigation under different parameters. Sedimentation assays using LUVs were used
as the primary experiment for quantitatively determining the interactions between
myo1c and phospholipids. This was an ideal system to use because it allowed us to do
in vitro experiments with a fluid bilayer system that mimicked the phospholipid bilayer
of the inner leaflet in the plasma membrane (Buser and McLaughlin 1998). Through
extrusion techniques, we were able to precisely control the radii of our LUVs to 50 nm,
as verified by DLS. This gave us a uniform binding substrate to work with, as well as
accurate control over the molar ratios of various lipid contained within the vesicles. All
sedimentation assays were performed using LUVs with PC as the background
phospholipid.
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3.1.1 Myo1c-Tail Binds LUVs Containing High Levels of PS

To determine if myo1c bound to lipid membranes containing PS, we tested the
binding of a myo1c construct containing the 3 IQ motifs and tail domain (myo1c-tail)
(Figure 11) to LUVs composed of 20% PS, 40% PS, 60% PS, and 80% PS in a PC
background using our sedimentation assay as illustrated (Figure 25A). Myo1c-tail, 40
nM, was sedimented in the presence of 0 – 400 µM LUVs. The pellets were run on an
SDS-PAGE gel and analyzed for the amount of myo1c-tail present. We plotted the
percentage of myo1c-tail bound as a function of lipid concentration to determine the
effective dissociation constants using Equation 4 and Equation 5, which were expressed
in terms of total lipid (Kefflipid) or accessible acidic phospholipid (Keffacidic), for the
interaction between myo1c-tail and LUVs containing varying amounts of PS in a
background of PC. We used a low concentration of myo1c-tail (40 nM) to ensure that
we stayed below the effective dissociation constant of myo1c : lipid.
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Figure 25 Total lipid vs.mol % binding assay

Figure 25A-B: A representation of the centrifuge tubes in the
sedimentation assays. Shown is a comparison between an increase in
concentration and an increase in mol %. A) An increase in the
concentration increases the number of LUVs, but keeps the density of
PIP2 (blue dots) constant. B) An increase in mole % increases the
density of PIP2 within the LUVs, but keeps the number of LUVs
constant.

83

We were unable to detect binding of myo1c-tail to LUVs containing only PC, or
to LUVs containing physiological molar concentrations of PS ~20% (Figure 26).
Myo1c-tail only bound to PS containing LUVs when the molar concentration of PS was
increased to 60% or higher. At these high, non-physiological concentrations of PS,
myo1c-tail bound with Kefflipid = 11 ± 2.0 µM (Keffacidic = 3.2 ± 1.0 µM) to 60% PS
LUVs, and with Kefflipid = 4.1 ± 0.70 µM (Keffacidic of 1.7 ± 0.060 µM) to 80% PS LUVs
(Table 1). These data confirmed previous studies showing that myosin-I bound to
anionic lipids (Adams and Pollard 1989; Hayden, Wolenski et al. 1990), and that its
binding was dependent on the molar concentration of PS (Tang, Lin et al. 2002);
however, it also showed that the association could not solely be based on non-specific
electrostatic interactions, as physiological levels of PS do not support binding.
Therefore, we hypothesized that for myo1c to bind to the membrane, additional factors
must be required.
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Figure 26 Sedimentation assays

Figure 26: The association of the myo1c-tail with LUVs. Lipid concentration
dependence of 40 nM myo1c-tail binding to LUVs composed of PC and () 0%
PS, () 20% PS, () 40% PS, () 60% PS, () 80% PS, () 2% PIP2, and
()20% PS + 2% PIP2. Each point is the average of 2-6 measurements. The
solid and dashed curves are the best fits of the 2% PIP2 and 20% PS + 2% PIP2
data to equation 2.4, respectively. The Keff of each data set is listed Table 1.
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Table 1 Effective dissociation constants for myo1c-tail binding to LUVs.

a

LUV composition

Kefflipid (M)c

Keffacidic (M)d

0% PS

> 400

N.A.

20% PS

> 400

> 40

40% PS

> 400

> 80

60% PS

11 ± 2.0

3.2 ± 1.0

80% PS

4.1 ± 0.70

1.7 ± 0.060

2% PIP2

23 ± 5.0

0.23 ± 0.050

2% PIP2 + 20% PS

± 1.5

0.44 ± 0.17

a

10 mM HEPES, pH 7.0, 100 mM NaCl, 1 mM EGTA, 1 mM DTT, 1 μM CaM

b

The mole percentages PS and PIP2 are reported with the remainder composed of PC.

c

Effective dissociation constants expressed in terms of total phospholipid. Errors are
standard errors of the fit.
d

Effective dissociation constants expressed in terms of accessible acidic phospholipid.
Errors are standard errors of the fit.
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3.1.2 Myo1c-Tail Binds LUVs Containing Low Levels of PIP2

We next studied binding interactions between myo1c and LUVs containing a
highly regulated and essential signaling phospholipid, PIP2, using our sedimentation
assay. Although the physiological concentrations of PIP2 in the inner membrane are
only 1 - 2 % (as compared to 20 - 30% for PS) (Verkleij, Zwaal et al. 1973), it has three
to four times the effective negative charge as PS and has been shown to bind
specifically to many membrane associated proteins (DiNitto, Cronin et al. 2003).
Myo1c-tail, 40 nM, was sedimented in the presence of 0 – 400 µM 2% PIP2 LUVs.
Myo1c-tail bound to 2% PIP2 LUVs in a PC background with Kefflipid = 23 ± 50 µM
(Keffacidic = 0.23 ± 0.050 µM) (Figure 26, Table 1). These data confirmed that the
interaction between myo1c and the plasma membrane could not be entirely electrostatic,
as myo1c bound tightly to LUVs composed of 2% PIP2 and not to LUVs comprised of
40% PS, which contained five to seven times the effective charge. Myo1c-tail clearly
showed a binding specificity to LUVs containing PIP2 over those containing PS.
We determined the affinity of myo1c-tail for 2% PIP2 + 20% PS LUVs to be
Kefflipid = 4.0 ± 1.5 µM (Keffacidic = 0.44 ± 0.17 µM) (Figure 26, Table 1). While the
affinity for accessible lipid was two-fold lower, the affinity for total lipid (which is
more relevant to membrane binding) was roughly six times greater than to LUVs of just
2% PIP2 alone. Therefore, although myo1c-tail did not bind to 20% PS alone, PS
appeared to demonstrate an additive effect when in the presence of 2% PIP2.
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3.1.3 Myo1c Membrane Binding is Salt Sensitive

To test if the binding of myo1c-tail to LUVs composed of PS or PIP2 has an
electrostatic component, we measured the binding as a function of the amount of NaCl
in solution. Binding data were fit to Equation 6, an abbreviated equation derived from
Debye-Hückel theory (Meltzer, Lurtz et al. 2006) that relates the change of dissociation
constants to the changes of ionic strength.
Myo1c-tail, 40 nM, and 60 µM LUVs were sedimented in the presence of 0 – 1
M NaCl. We found that the interaction of myo1c-tail to 2% PIP2 LUVs had a slightly
higher dependence on the ionic strength of the solution than with 60% PS LUVs (Figure
27A). A fit of the data to Equation 6 yielded net charges of -4.7 and -1.6 with
interaction distances of 0.43 and 0.12 nm for 60% PS and 2% PIP 2 respectively (Figure
27B). Considering that PIP2 has a net charge of -4 at pH 7.0, if we assumed 1:1 binding
between myo1c and PIP2, the effective charge for the region of myo1c-tail that interacts
with PIP2 would be 0.39, while the region that interacts with PS, charge of -1, would be
4.7. This implied that if the same region of myo1c-tail interacts with both PIP2 and PS,
up to 12 molecules of PS could be required for tight binding.
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Figure 27A-B: The effect
of

ionic

strength

on

binding

to

myo1c-tail
LUVs.

A) Dissociation

of 40 nM myo1c-tail
from 60 µM 60% PS ()
or 2% PIP2 () LUVs as
a dependence of NaCl
concentration.

B)

The

same data plotted as the
log of the Kd as a
function of the squareroot of the ionic strength.
The solid and dashed
curves are the best fits of
the 2% PIP2 and 60% PS
data

to

Equation

respectively.
Figure 27 Salt dependence and Debye Hückel
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6,

3.1.4 Myo1c Does Not Cluster PIP2

Some PIP2 binding proteins, such as MARCKS, have been shown to cluster
multiple PIP2 molecules within close proximity to increase the density of anionic
charges (Gambhir, Hangyas-Mihalyne et al. 2004). We used FRET to determine if
myo1c was able to cluster PIP2 labeled at the ends of one of its acyl chains with a donor
fluorophore, FL, and PIP2 labeled at the ends of one of its acyl chains with an acceptor
fluorophore, TMR, on LUVs.
We measured the steady state fluorescence signal from FRET for both 0 – 5 µM
MARCKS peptide and 0 – 10 µM myo1c-tail bound to 200 or 250 µM LUVs containing
0.8% of fluorescently labeled PIP2 and plotted the ratios of TMR/FL emission spectra as
a function or protein concentration. We observed no change in the FRET ratio with the
addition of up to 1 µM myo1c-tail (Figure 28A), but saw a significant decrease in the
FRET ratio with the addition of MARCKS peptide that appeared to saturate at around
10 µM (Figure 28B). This was due to a significant decrease in emission of FL at 514.5
nm, but little increase in the emission of TMR at 572.5 nm (Figure 28C). As a control,
we confirmed that myo1c-tail was able to bind to LUVs containing 0.8% fluorescently
labeled PIP2 by using our standard binding assay. Although we did not observe a true
FRET signal between our fluorescently labeled PIP2 with the addition of MARCKS, the
decrease of TMR fluorscence suggests that MARCKS affected the lateral distribution of
PIP2 in LUVs, whereas myo1c-tail did not.
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Figure 28A-C: FRET ratios from
PIP2 clustering. LUVs containing
0.5% (), 0.8% (), or 1.2% ()
FL and TMR labeled PIP2 were
incubated

with

increasing

concentrations of A) myo1c-tail,
or B) MARCKS peptide.
ratio

of

TMR

The

fluorescence

measured at 514.5 nm over FL
fluorescence measured at 572.5
nm is plotted as a function of
protein.

C) Raw fluorescence

spectra of FL and TMR emissions
with increasing concentrations of
MARCKS.

Figure 28 Myo1c and MARCKS FRET
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3.1.5 Cooperative Binding of PIP2

Membrane association of certain PIP2 binding proteins, e.g. MARCKS
(McLaughlin, Wang et al. 2002) and N-WASP (Papayannopoulos, Co et al. 2005),
requires cooperative binding. A minimum negative density threshold must exist before
binding occurs, which results in a sigmoidal binding curve (Figure 29A). This is in
contrast to proteins that bind to PIP2 directly and do not require multiple PIP2 molecules
to bind. Examples of this are PPB PH domain containing proteins, which have a
hyperbolic binding curve (Figure 29B).

A
Figure 29A-B: Figures are taken
from (Papayannopoulos, Co et al.
2005). Binding isotherms for A) NWASP, and B) PLCδ-PH were
measured

with

a

perturbation

assay

Cooperative

binding

fluorescence
from.
requiring

A)
a

minimal density of PIP2 before

B

binding occurs. Note the lag phase
from 0 – 2 Mol% PIP2. B) Direct
binding to the head group of PIP2
does not require a minimum density
of PIP2.

Figure 29 Cooperative binding curves
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To determine if myo1c bound PIP2 in a cooperative manner, we measured 40
nM myo1c-tail binding to increasing molar concentrations of PIP2 while maintaining
the same total lipid concentration at either 30 or 60 µM (Figure 25B). The resulting
binding curve of myo1c-tail bound as a function of increasing molar concentrations of
PIP2 had a hyperbolic dependence (Figure 30), signifying that the binding was not
cooperative; if binding was cooperative, then we would have expected to see a
sigmoidal binding curve with a lag-phase at low molar concentrations of PIP2.
Moreover, when we plotted the percentage of myo1c-tail bound from our previous 2%
PIP2 binding experiments at varying lipid concentrations as a function of the
concentration of accessible PIP2 (Figure 30 inset), we found the concentration
dependence of binding to be nearly identical. This mode of binding supported our
previous conclusions from our stoichiometric data, suggesting that the binding ratio of
myo1c to PIP2 is 1:1.
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Figure 30 Myo1c binding as a function of mol% PIP2

Figure 30: Figure was originally published in (Hokanson and Ostap 2006). Binding
of 40 nM myo1c-tail to 30 µM LUVs (total lipid) composed of 0 – 10% PIP2. The
percent of membrane-bound myo1c-tail is plotted as a function of the percentage of
PIP2 in the LUVs, rather than total lipid concentration. Each point is the average of
three measurements. (Inset) The same data plotted as a function of the accessible
PIP2 concentration (○). Data in the inset also include the percent of 40 nM myo1ctail bound to () 60 M LUVs containing 0 - 5% PIP2 and (●) 0 – 400 µM LUVs
containing 2% PIP2 from Figure 22.
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3.1.6 Calcium and CaM Myo1c-Tail Binding 2% PIP2 LUVs

It had been proposed that the lipid binding site of myo1c was located in the
regulatory domain and not in the tail domain (Swanljung-Collins and Collins 1992;
Tang, Lin et al. 2002; Hirono, Denis et al. 2004). This model suggested that lipid
binding required Ca2+-dependent conformational changes in one or more CaM bound to
the three IQ motifs in the regulatory domain.

This conformational change or

dissociation of CaM from an IQ motif was proposed to have the potential to expose
basic polypeptide stretches that might be responsible for binding to anionic lipids
(Figure 31). In order to test this model, we measured the effects of both Ca2+ and CaM
on the steady-state binding of myo1c-tail to LUVs composed of 2% PIP2 or 20% PS.

2+

Figure 31 Ca regulation of CaM reveals lipid binding site

Figure 31: A cartoon showing a proposed effect of Ca2+ revealing a
lipid binding site. High levels of Ca2+ change the conformation and
cause at least one bound CaM (blue bars) to dissociate. This reveals
a basically charged IQ motif which could interact with acidic lipids
shown in red.
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Myo1c-tail, 40 nM, was sedimented in the presence of 0 – 200 µM LUVs with
or without 10 µM free Ca2+, or 40 nM myo1c-tail was sedimented with 60 µM LUVs in
the presence of 0 – 100 µM CaM. We determined that the interaction of myo1c-tail and
LUVs was neither inhibited by the addition of up to 100 µM CaM (Figure 32A), nor
was there a significant increase in affinity in the presence of 10 µM free Ca2+ (Figure
32B). We concluded that the binding of myo1c-tail to 2% PIP2 LUVs was not affected
by an increase in Ca2+ levels and was not dependent on the conformational changes of
CaM bound to the IQ motifs.

Figure

32A-B:

Figures

were

originally published in (Hokanson
and Ostap 2006).

(A)

40 nM

myo1c-tail binding to 60 M LUVs
containing (●) 2% PIP2 or (▲) 60%
PS LUVs in the presence of 0-100
M calmodulin. Each point is the
average of two measurements. (B)
40 nM myo1c-tail binding to 0 - 400
µM LUVs containing 2% PIP2 in the
(●) absence and (○) presence of 10
µM free calcium. The solid line is
the

best

fit

to

a

rectangular

hyperbola. Error bars represent ± 1
standard deviation (n = 4-6).
2+

Figure 32 CaM and Ca dependence of myo1c-tail binding to PIP2
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3.1.7 Regulatory Domain Binds to PS with a Calcium Dependence

To further test if there were any contributions from the regulatory domain of
myo1c for lipid binding, we ascertained the affinity of a myo1c construct containing the
motor domain followed by the 3 IQ motifs (myo1c-motor) (Figure 11) for LUVs. This
construct was designed to lack the tail domain so that the only possible lipid binding
site would be the motor or regulatory domains. We tested the binding of 40 nM myo1cmotor to 0 – 200 µM LUVs composed of 20% PS, 40% PS, 60% PS, 80% PS, 2% PIP2,
and both 20% PS + 2% PIP2 all in a PC background, in the absence and presence of 10
µM free Ca2+ using our sedimentation assays (Figure 33). In the absence of Ca2+,
myo1c-motor bound weakly to 40% PS LUVs (99 ± 24 µM), whereas 60% PS and 80%
PS LUVs bound with affinities of 37 ± 5.6 µM and 23 ± 3.3 µM respectively (Table 2).
In the presence of 10 µM free Ca2+, the affinity of myo1c-motor for ≥ 40% PS LUVs
increased ~10-fold to as high as 0.42 ± 0.27 µM for 80% PS LUVs; this was consistent
with the proposal that positive charges in the IQ motif were revealed upon Ca2+-induced
dissociation of CaM.
Physiological levels of PS in biological membranes are ~ 20% - 30% PS, so it is
unlikely that myo1c binding to high PS concentrations is physiologically relevant.
However, it is possible that additional factors in the cell could cause PS to cluster and
form micro-domains (Murray, Arbuzova et al. 1999). Given that our data showed a
six-fold increase in affinity of myo1c-tail for 20% PS + 2% PIP2 LUVs over that of 2%
PIP2 LUVs (Table 3.1), it was more likely that low concentrations of PS contributed to
the

binding

energy

when

myo1c

was
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attached

to

the

membrane

via

phosphatidylinositols. Therefore, we concluded that it was the tail domain of myo1c
that was responsible for localization and binding to the membrane.

Although the

regulatory domain may have stabilized this interaction in a Ca2+ regulated manner once
myo1c was already bound to the membrane through PIP2, it was not sufficient for
membrane binding alone.
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2+

Figure 33 Myo1c-motor binding is Ca dependent

Figure 33: Figure was originally published in (Hokanson, Laakso et al. 2006).
Lipid concentration dependence of 40 nM myo1c-motor binding to LUVs
composed of PC and 20% PS, 40% PS, 60% PS, 80% PS, 2% PIP2, and 20% PS +
2% PIP2 in the () absence and () presence of 10 µM free calcium. Each point
is the average of 2 - 6 measurements. The solid and dashed curves are the best fits
of the data to hyperbolae. The Kefflipid of each data set is listed in Table 2.
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Table 2 Effective dissociation constants for myo1c-motor binding to LUVs.

LUV Compositionb

a

Kefflipid (M)c

Kefflipid (M)c

- Ca2+

+ Ca2+

20% PS

> 400

> 400

40% PS

99 ± 24

11 ± 1.5

60% PS

37 ± 5.6

3.2 ± 0.83

80% PS

23 ± 3.3

0.42 ± 0.27

2% PIP2

> 400

> 400

2% PIP2 + 20% PS

> 400

> 400

a

10 mM HEPES, pH 7.0, 100 mM NaCl, 1 mM EGTA, 1 mM DTT, 1 μM CaM

b

The mole percentages PS and PIP2 are reported with the remaining lipid composed of PC.

c

Effective dissociation constants expressed in terms of total phospholipid. Errors are
standard errors of the fit.

100

3.2 Inositol Phosphate Binding and Inhibition Studies
In cells, many phosphatidyl inositols are hydrolyzed to form DAG and a soluble
inositol phosphate by phospholipases (Figure 7). It was important for us to determine if
myo1c was able to bind to the soluble head groups of phosphatidyl inositols. Polybasic
proteins, e.g. MARCKS and N-WASP, are unable to bind soluble phosphatidyl inositol
derivatives because they are not accessible in a multivalent manner like PIP 2 in the
membrane (Papayannopoulos, Co et al. 2005). Phosphatidyl inositol binding proteins
that have a specific interaction with the inositol head group bind to the phosphorylated
inositol ring directly through an electrostatic association with the charged phosphates.
The most studied is PLCδ-PH, which binds to Ins(1,4,5)P3 as well as PIP2 (Lemmon,
Ferguson et al. 1995). Determining whether myo1c bound directly to the inositol ring
would give insight into the mechanism of binding.
A secondary reason for determining if myo1c directly bound to inositol
phosphates was the ability to test for inositol phosphorylation stereospecificity. Many
relevant phosphatidylinositols were not available from biochemistry reagent suppliers,
and those that were did not easily go into solution and/or did not contain long acyl
chains that would ensure their incorporation into LUVs. A variety of soluble inositol
phosphates were readily available from biochemistry reagent suppliers.
By using competitive inhibition binding studies, we were able to measure the Kd
of myo1c-tail for a variety of inositol phosphates. We assumed that the myo1c-tail
binds PIP2 with a 1:1 stoichiometry and that myo1c-tail has an affinity of Keffacidic = 0.23
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µM for PIP2. Data was fit to Equation 8 to calculate binding affinities of inositol
phosphates that bound to the PIP2 binding site of myo1c-tail and displaced it from the
LUVs. This fit also enabled us to determine the affinity for PIP2 of proteins that
displaced myo1c-tail from the LUVs by binding to PIP2.

3.2.1 Myo1c and PLCδ-PH Domain Compete for PIP2 Binding

To determine if myo1c-tail bound to the same site on PIP2 as the canonical PIP2
binding protein, PLCδ-PH, we tested if PLCδ-PH could competitively bind PIP2
containing LUVs in the presence of myo1c-tail. Myo1c-tail, 100 nM, was sedimented
in the presence of 60 µM 2% PIP2 LUVs and 0-10 µM PLCδ-PH (Figure 34). We
found that PLCδ-PH was able to effectively displace the myo1c-tail from the LUVs in a
dose dependent manner. We calculated an effective dissociation constant for PLC-PH
binding to PIP2 of Keff = 0.30 ± 0.030 M, which was in close agreement with
previously determined values (Lemmon, Ferguson et al. 1995).
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Figure 34 Myo1c and PLCδ-PH compete for PIP2

Figure 34: Figure was originally published in (Hokanson and Ostap 2006). Binding
of 100 nM myo1c-tail to 60 µM LUVs containing 2% PIP2 in the presence of 0 – 10
µM PLC-PH. The inset is a SYPRO-red stained SDS-PAGE gel showing LUVbound (top) myo1c-tail and (bottom) PLCδ-PH as a function of total PLCδ-PH
concentration.
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3.2.2 Myo1c Binds Directly to Ins(1,4,5)P3

To ascertain whether myo1c-tail bound to the head group of PIP2 directly, we measured
its ability to bind [3H]-labeled Ins(1,4,5)P3 by gel filtration chromatography (Figure
35A-C). We used PLC-PH as a positive control because it had previously been shown
to bind tightly to Ins(1,4,5)P3 (Lemmon, Ferguson et al. 1995). Both PLC-PH and
myo1c-tail eluted as single peaks from gel filtration columns. When PLC-PH and
myo1c-tail were run with two-fold molar excess [3H]-Ins(1,4,5)P3, [3H]-Ins(1,4,5)P3
eluted as two peaks, one co-eluting with the PLC-PH or myo1c-tail, demonstrating a
stable interaction, and the other corresponding to free [3H]-Ins(1,4,5)P3. As a negative
control, [3H]-Ins(1,4,5)P3 eluted as a single, non-protein-bound peak when run on the
gel filtration column with GST, a protein that does not bind Ins(1,4,5)P3. The elution
position of protein was determined by absorbance at 280 nm. Scintillation counting was
used to detect the 3H-Ins(1,4,5)P3 elution position. These results suggest that myo1c
bound to Ins(1,4,5)P3 directly.
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Figure 35A-C: Figures were
originally

published

in

(Hokanson and Ostap 2006).
Myo1c-tail binds InsP3.

Gel

filtration elution profiles of
samples containing (A) 10 µM
PLC-PH, (B) 10 µM myo1ctail, or (C) 10µM GST in the
presence

of

excess

3

H-

Ins(1,4,5)P3. The concentrations
of InsP3 (solid lines) and PLCPH or myo1c-tail (dotted lines)
are shown.

InsP3 run in the

absence of protein in a separate
experiment

is

also

shown

(dashed line) as a reference
elution profile.

Figure 35 Gel filtration assay
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3.2.3 Myo1c Binds Inositol Phosphates Promiscuously

To determine if myo1c binds to additional inositol phosphates, we tested the
affinity of myo1c-tail for nine inositol phosphates by competitive binding.

We

measured the ability of Ins(3)P1, Ins(1,3,4)P3, Ins(1,4,5)P3, Ins(1,2,6)P3, Ins(1,3,4,5)P4,
Ins(1,2,5,6)P4, Ins(1,3,4,6)P4, Ins(1,2,3,5,6)P5, and InsP6 to compete with 2% PIP2
LUVs for binding to myo1c-tail (Figure 36).
Inositol phosphates (0 – 50 μM) were mixed with 50 nM myo1c-tail and 60 µM
2% PIP2 LUVs. At these concentrations, ~ 80% myo1c-tail was bound to the LUVs in
the absence of inhibitor. Eight of the nine inositol phosphates, when fit to Equation 4,
gave results within a factor of three ranging from 96 ± 32 nM for Ins(1,4,5)P3 to 33 ± 7
nM for Ins(1,3,4,5)P4. The one exception that we obsevered was Ins(1,2,6)P3, which
had a 10-fold lower affinity of 630 ± 130 nM (Table 3). These affinities were over 2fold tighter binding than our measured affinity of myo1c-tail for PIP2 (Keffacidic = 0.23 ±
0.050 µM), which suggested that Ins(1,4,5)P3 may be able to effectively displace myo1c
from the plasma membrane in the cell; however, additional binding energies contributed
by PS binding may prevent this from occurring. The mono-inositol phosphate, Ins(3)P1,
failed to inhibit the interaction of myo1c with PIP2 at concentrations up to 100 µM.
These results suggested that the binding of myo1c-tail to phosphatidyl inositols is not
solely dependent on the number of charges, but also on the positions of the charges.
Moreover, myo1c may have some inositol phosphate binding specificity for phosphates
at the 4 and 5 positions of the inositol ring, as the affinity of myo1c for Ins(1,2,6)P 3 is
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10-fold weaker than all other inositol phosphates that contain a phosphate at one or both
of these ring positions.

Figure 36 InsPx competitive binding assay (PIP2)

Figure 36: Figure was originally published in (Hokanson, Laakso et al. 2006).
Binding of 40 - 100 nM myo1c-tail to 60 µM LUVs containing 2% PIP2 in the
presence of 0 – 50 µM () Ins(1,4,5)P3, () Ins(1,3,4)P3, () Ins(1,2,6)P3, ()
Ins(1,3,4,5)P4, () Ins(1,2,5,6)P4, () Ins(1,3,4,6)P4, () Ins(1,2,3,5,6)P5 and
() InsP6 (n for each point = 4 - 14). Solid lines are fits to the () Ins(1,3,4,5)P4
and () Ins(1,2,6)P3 using Equation 4. Points at 0 µM InsPx are not shown due
to logarithmic scale. The effective dissociation constants obtained from the fits
are listed in Table 3.
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Table 3 Effective dissociation constants for inositol phosphates binding to myo1c-tail.

a

Inositol Phosphateb

Kdc

Ins(3)P1

> 1 µM

Ins(1,4,5)P3

96 ± 32 nM

Ins(1,3,4)P3

61 ± 25 nM

Ins(1,2,6)P3

630 ± 130 nM

Ins(1,3,4,5)P4

33 ± 7.0 nM

Ins(1,2,5,6)P4

53 ± 23 nM

Ins(1,3,4,6)P4

67 ± 17 nM

Ins(1,2,3,5,6)P5

44 ± 14 nM

InsP6

48 ± 16 nM

a

10 mM HEPES, pH 7.0, 100 mM NaCl, 1 mM EGTA, 1 mM DTT, 1 μM CaM

b

The mole percentages PS and PIP2 are reported with the remaining lipid composed of PC.

c

Effective dissociation constants were determined by competition assays as described in
Materials and Methods. Errors are standard errors of the fit.
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3.2.4 Ins(1,4,5)P3 Competes Weakly with Myo1c-Tail for PS Binding

We hypothesized that if the binding of myo1c to PS was due to a separate
binding site than that for PIP2, Ins(1,4,5)P3 should not be able to inhibit binding of
myo1c-tail to LUVs comprised of PS.

We repeated our Ins(1,4,5)P3 competition

binding studies using 50 nM myo1c-tail bound to 60 µM LUVs composed of 2% PIP2 +
20% PS, 2% PIP2 + 60% PS, 20% PS, 60% PS, and 80% PS (Figure 37). Only weak
inhibition was seen with up to 50 µM Ins(1,4,5)P3 as most of the myo1c-tail remained
bound to LUVs comprised of 2% PIP2 + 20% PS or 2% PIP2 + 60% PS. Myo1c-tail
also remained mostly bound to LUVs of 60% and 80% PS with Ins(1,4,5)P3
concentrations up to 50 µM.
We interpreted this data to signify that myo1c contained two separate binding
sites. One site bound tightly and specifically to phosphatidyl inositols in a 1:1 ratio and
could be inhibited by inositol phosphates; a second site bound to PS or anionic lipids in
a Ca2+ dependent manner and was not inhibited by inositol phosphates. When both sites
were bound to their respective substrates, i.e. LUVs with 2% PIP2 + 20% PS, binding
was six-fold tighter (Table 1) and myo1c was not displaced from the LUVs by
Ins(1,4,5)P3.
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Figure 37 Ins(1,4,5)P3 competitive binding assay

Figure 37: Binding of 50 nM myo1c-tail to 60 µM LUVs composed of (,
solid line) 2% PIP2, ( uneven dashed line) 2% PIP2 + 20% PS, (, thin
dashed line) 2% PIP2 + 60% PS, (, lowest dashed line) 20% PS, (,
dotted line) 60% PS, and (, long dashed line) 80% PS (n for each point =
4 - 14). Lines are fits to the using the Equation 4. Points at 0 µM InsPx are
not shown due to logarithmic scale.
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3.2.5 Ins(1,4,5)P3 Protects Myo1c-Tail from Trypsin Digest

We found that Ins(1,4,5)P3 protects myo1c-tail from trypsin digestion while
attempting to obtain a small, stable construct of the lipid binding domain of myo1c.
100 µL aliquots of 0.3 mg/mL myo1c-tail were incubated with trypsin concentrations
ranging from 0.15 - 3.0 µg/mL trypsin over 0 - 40 minutes before the reaction was
quenched by the addition of equal amounts by weight of soybean inhibitor (SI).
Myo1c-tail fragments were detected by Western blot and SYPRO red analysis (Figure
38A-B). A 1:1000 ratio by weight of trypsin to myo1c-tail for 40 minutes, or a 1:100
ratio by weight of trypsin to myo1c-tail for 10 minutes effectively digested the myo1ctail to near completion. Digestion fragments from a 1:1000 ratio by weight of trypsin to
myo1c-tail can be clearly seen in the SYPRO red stained gel after 5 minutes (Figure
38B). A 1:100 ratio by weight of trypsin to myo1c-tail sample with 10 µM Ins(1,4,5)P3
was not digested after 10 minutes, whereas a sample with no Ins(1,4,5)P3 was almost
fully digested. Similar results have shown that myo1a is protected by lipid vesicles
when digested with α-chymotrypsin (Hayden, Wolenski et al. 1990). We conclude from
this finding that Ins(1,4,5)P3 helped to protect myo1c-tail from trypsin digestion,
possibly by stabilizing a folded conformation or blocking one or more cleavage sites.
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Figure 38 Myo1c-tail digest

Figure 38A-B: Western blot and SYPRO red stained SDS-PAGE gel of a myo1ctail trypsin digest.

A)

Digestion times were 5, 10, 20, 40 minutes at three

dilutions. Lanes 1 – 4 1:100 trypsin by weight, lanes 5 – 8 1:500 trypsin by weight,
lanes 9 – 12 1:1000 trypsin by weight. B) Digestion times were 0, 5, 10 minutes at
three dilutions. Lanes 1 – 3 1:1000 trypsin by weight, lanes 4 – 6 1:2000 trypsin by
weight, lanes 7 - 9 1:100 trypsin by weight in the presence of 10 µM Ins(1,4,5)P3.
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3.3 In Vivo Localization Studies
We sought to show that the localization of myo1c in mammalian cells was
consistent with the data from our in vitro binding assays. To test this, we expressed a
myo1c-tail construct with a GFP-tag at the N-terminus in mammalian cells. We found
that when a GFP-myo1c-tail chimera was expressed, it localized to the plasma
membrane as shown previously (Figure 39) (Ruppert, Godel et al. 1995; Bose,
Guilherme et al. 2002). We further used this construct to show that myo1c concentrated
on cellular PIP2 containing structures. All of our constructs expressed in various cell
types showed no dominant inhibitory effects to any of the cell processes we checked for
including ruffling, lamellipodia retraction, filopodia, presence of vesicles, cell size, or
mitosis (Figure 40).
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Figure 39 Myo1c-tail localization

Figure 39: The localization of myo1c-tail by epifluorescence.

Four

different cell types, A) NRK, B) CHO, C) COS-7, and D) HeLa, were
transfected with GFP-tail and observed under epifluorescence. Note the
punctuate staining and membrane localization in each cell type.
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Figure 40 No dominant negative effect

Figure 40: Epifluorescence of CHO cells transfected with GFP-tail.
Top images show fluorescence of actin labeled with rho-phalloidin.
Bottom images show fluorescence of GFP-tail. The focal plane of
images on left are focused at the top of the cells to observe
filopodia, the focal plane of images on the right are focused at the
edges of the cell.
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3.3.1 Ionomycin Redistributes Myo1c-Tail to the Cytoplasm

PLC hydrolyzes PIP2 into two second messengers, DAG, which is retained in
the membrane, and Ins(1,4,5)P3, which is soluble and contains the phosphorylated
inositol ring. We hypothesized that the tail domain of myo1c should localize to the
plasma membrane and translocate to the cytoplasm upon calcium activation of PLC if it
binds tightly to cellular PIP2 (Ryu, Suh et al. 1987). To observe changes in localization
of myo1c after Ca2+-induced activation of PLC, we added CaCl2 and ionomycin, an
ionophore which allows Ca2+ to cross the plasma membrane.
The addition of 10 μM ionomycin and 1.2 mM CaCl2 to the growth medium of
NRK cells expressing GFP-myo1c-tail resulted in the redistribution of GFP-myo1c-tail
to the cytoplasm (Figure 41).

The GFP-myo1c-tail reassociated with the plasma

membrane upon washing out the CaCl2 and ionomycin. In consideration of this result,
we kept in mind that increased levels of Ca2+ in the cell from the addition of ionomycin
can affect other factors in addition to activating PLC, all of which could potentially
have inhibited myo1c localization. The two most obvious possibilities we considered
were the activation of scramblases, which flip PS molecules to the outside of the cell
and deplete their effective concentration on the inner-leaflet, and electrostatic shielding
at the plasma membrane. Although this assay was relatively non-specific, it supported
our findings that the myo1c-tail bound to PIP2 and that calcium did not increase the
affinity of myo1c for the plasma membrane.
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Figure 41 Ionomycin redistributes myo1c-tail

Figure 41: Figure was originally published in (Hokanson and Ostap 2006).
Cellular distribution of GFP-tail during influx of calcium. Fluorescence
micrographs of a transfected NRK cell showing GFP fluorescence before,
during, and after incubation with 10 μM ionomycin in medium containing
1.2 mM CaCl2. Scale bar is 15 μm.
3.3.2 Myo1c Found on Cellular PIP2-Containing Structures

In addition to localizing to the plasma membrane, myo1c was found on cellular
structures known to be enriched in phosphatidyl inositols. In NRK cells undergoing
macropinocytosis, we found that GFP-myo1c-tail transiently concentrated on the
membrane during the early phases of membrane internalization (Figure 42). Once the
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macropinosome separated from the plasma membrane, the GFP-myo1c-tail dissociated
from the membrane. This transient localization closely mirrored the localization of
PIP2-specific PH domains during macropinocytosis and phagocytosis (Cullen, Cozier et
al. 2001; Simonsen, Wurmser et al. 2001), again supporting the proposal that myo1c
primarily bound to cellular PIP2.

Figure 42 Macropinocytosis event

Figure 42: Figure was originally published in (Hokanson and Ostap 2006).
Cellular distribution of GFP-tail during macropinocytosis.

Fluorescence

micrographs of a transfected NRK cell showing GFP fluorescence around a newly
internalized macropinosome (arrow).

Note the loss of fluorescence around

macropinosome after it is internalized. The time stamp is min:sec, and the scale
bar is 5 μm.
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3.4 Identifying the PIP2 Binding Site
Finding sequence homology to a PIP2 binding domain proved to be quite
difficult, as there was no structural information known and very little sequence
homology found to the tail domain of myo1c in the databases. In addition, there was
evidence that the myo1c tail domain may be extended and flexible due to its lack of
density in electron micrographs of helical reconstructions of myo1a saturated actin
filaments (Figure 48) (Jontes and Milligan 1997). Therefore, we followed the advice of
Dr. Mark Lemmon (University of Pennsylvania) and turned to algorithms that predict
secondary structure and match those to protein domains of known structures. From
these, we were able to identify the region in the tail domain that binds to the membrane
and locate residues directly responsible for PIP2 binding.

3.4.1 Identification of a Putative PH Domain

Our searches in the NCBI database for PIP2 binding proteins with sequence
homology to myo1c yielded negative results. Undeterred, we searched for structural
homologs

of

the

myo1c

(www.sbg.bio.ic.ac.uk/phyre/) to

tail

domain

identify a

using

the

phosphatidylinositol

Phyre

server

binding site.

Secondary structural analysis revealed that the myo1c tail domain had homology to PH
domains, including specific sequence homology to the β1-loop-β2 phosphatidylinositol
binding region (Figure 10) of PPB PH domains (Isakoff, Cardozo et al. 1998). This
region contained the PH domain signature motif of conserved basic residues (K-Xn-
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(K/R)-X-R) (Isakoff, Cardozo et al. 1998; Cronin, DiNitto et al. 2004), which we
identified in myo1c (Figure 43A).
Two of the conserved basic residues in the β1-loop-β2 region of PH domains
have been shown to be crucial for high affinity poly-phosphatidylinositol binding
(Cronin, DiNitto et al. 2004). To determine if these residues also play a role in myo1cPIP2 interactions, we mutated the corresponding amino acids in a GFP-tail construct to
alanines (GFP-tail-K892A and GFP-tail-R903A) (Figure 11). We expressed GFP-tail,
GFP-tail-K892A, and GFP-tail-R903A in HEK-293T cells, and purified these proteins
using a two-step purification scheme as described in chapter 2. The impact of these
mutations on myo1c binding to PIP2 will be discussed below.
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Figure 43 PH domain signature motif

Figure 43A-C: Figures were originally published in part in (Hokanson, Laakso et
al. 2006). Alignment of mouse myo1c (residues 884 - 908) with the (A) β1-loopβ2 motif of PH domains, B) vertebrate myosin-I isoforms, and C) eukaryotic
myosin-Is. Red bands and residues indicate conserved known basic residues
important for membrane binding in PH domains, orange residues indicate all other
basic residues, brown residues indicate conserved hydrophobic patch following
the second key residue of β2, purple residues indicates conserved threonine at end
of β2.
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3.4.2 Signature PH Domain Motif Found in Many Eukaryotic Myosin-Is

There are eight myosin-Is expressed in humans, myo1a through myo1g. We
were able to identify the PH domain signature motif (K-Xn-(K/R)-X-R) in all six shorttail myosin-Is (Figure 43B). Therefore, we hypothesized that these short-tail isoforms
bind to phosphatidylinositols in a manner similar to myo1c. The two myosin-Is that did
not contain the PH domain signature motif were myo1e and myo1f, the two long-tail
isoforms of myosin-I. Long-tail myosin-Is have the addition of an SH3 and GP-rich
domain in a C-terminal extension of their tail domains that starts after the first β-strand
of the identified PH domain signature motif. This extension contains several positive
charges that may be positioned for phosphatidylinositol binding. Long-tail myosin-I
isoforms have been shown to bind acidic phospholipids (Adams and Pollard 1989;
Stoffler, Ruppert et al. 1995), so it is possible that differences in this region may result
in differences in membrane binding properties.
We also identified the PH domain signature motif in myosin-Is from other
Eukaryotic species, including 61F and 31DF from Drosophila, hum-5 and hum-1 from
C. elegans, and Myo3 and Myo5 from S. cerevisiae (Figure 43C). These myosin-Is
may also bind to phosphatidylinositols in a manner similar to myo1c.

3.4.3 Point Mutations Inhibit PIP2 Binding

We used sedimentation assays to calculate the effective dissociation constants,
which are expressed in terms of total lipid (Kefflipid) or accessible acidic phospholipid
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(Keffacidic), for the interaction between GFP-tail, GFP-tail-K892A, and GFP-tail-R903A
and sucrose-loaded 2% PIP2 LUVs (Figure 44). GFP-tail, GFP-tail-K892A, and GFPtail-R903A were sedimented in the presence of 0 – 400 µM LUVs. The supernatants
were analyzed for the presence of GFP using a fluorimeter with a double
monochromator to decrease the amount of light-scattering caused by the LUVs.
Because the constructs were GFP fusion proteins, we were able to determine the
fraction bound as a function of lipid concentration by monitoring the loss of
fluorescence in the supernatant. The GFP-tail bound with Kefflipid = 24 ± 2.4 μM
(Keffacidic = 0.24 ± 0.024 μM), which is almost identical to the Kefflipid for a myo1c-tail
construct expressed in sf9 cells that does not contain GFP (Table 1). Remarkably, we
did not detect any binding of GFP-tail-K892A and GFP-tail-R903A mutants to LUVs
containing 2% PIP2 at total lipid concentrations of up to 400 µM.

123

Figure 44 Association of GFP-tail constructs with PIP2

Figure 44: Figure was originally published in (Hokanson, Laakso et al.
2006). Lipid concentration dependence of () 6.9 nM GFP-tail, ()
9.7 nM GFP-tail-K892A, and () 15 nM GFP-tail-R903A binding to
LUVs composed of 2% PIP2.

Each point is the average of two

measurements. The solid line is the best fit of the GFP-myo1c-tail data
to a hyperbola, yielding, Kefflipid = 53 ± 11 μM.
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3.4.4 Full-Length Myo1c Localization is Identical to Myo1c-Tail

In all cell types tested (NRK, COS-7, CHO, HeLa, and 293T), GFP-tail was
localized to the cell membrane and was concentrated in regions of membrane ruffling
and retraction (Figure 39), as reported previously for endogenously expressed myo1c in
NRK cells (Ruppert, Godel et al. 1995) and GFP-myo1c in NIH3T3 cells (Bose,
Guilherme et al. 2002). In NRK cells, full length GFP-myo1c constructs that contained
the K892A (GFP-myo1c-K892A) and R903A (GFP-myo1c-R903A) mutations were
localized to the cytoplasm, with no significant population in the dynamic cell margins
(Figure 45). Therefore, no significant population of GFP-myo1c-K892A and GFPmyo1c-R903A bound to the plasma membrane. We also tested a GFP-tail construct
with a K296A mutation. This construct showed identical localization to GFP-tail,
suggesting that not all basic residues in this region are essential for membrane
association, and that membrane binding is not based on charge alone.
To test for dominant negative effects on motility and cell morphology,
particularly at the cell edge, we over expressed GFP-myo1c-tail, GFP-myo1c-tailK903A, and GFP-myo1c-K903A in NRK, COS-7, and CHO cells. We were unable to
detect any differences in transfected versus nontransfected cells regarding cell size,
ruffling, lamellipodia, filopodia, endocytosis, mitosis, and cell motility.
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Figure 45 GFP-my1oc constructs localization

Figure 45: Figure was originally published in (Hokanson, Laakso et al.
2006). Epifluorescence micrographs of live NRK cells expressing (top)
GFP-myo1c, (center) GFP-myo1c-K892A, and (bottom) GFP-myo1cR903A. The boxes outline the expanded regions shown in the right column.
Note the localization of wild-type GFP-myo1c within the membrane ruffles
and macropinocytic regions, but not in the mutated proteins. The scale bars
are 15 µm.
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3.5 TIRF/FRAP Dissociation Studies
TIRF is a technique designed to reduce the background fluorescence of a
specimen due to the nature of the evanescent electromagnetic field, which decays
exponentially from the interface and thus penetrates to a depth of approximately 100 nm
into the sample medium. We combined TIRF with FRAP to measure dissociation rates
of membrane-bound myo1c. This technique allowed us to monitor events that occurred
at and directly above the plasma membrane without the background fluorescence of the
entire cytosol.

3.5.1 Point Mutations in the Putative PH Domain Affect Myo1c Localization

We monitored membrane association of GFP-tail, GFP-tail-K892A, and GFPtail-R903A by TIRF/FRAP microscopy in live NRK cells to determine if the K892A
and R903A mutations affect the dynamics of in vivo membrane binding (Figure 46).
The fluorescence of all constructs was visible by TIRF microscopy, as was the
fluorescence from cells expressing GFP only.
of GFP-tail recovered in two phases.

The fluorescence after photobleaching

A fast phase (kfast) recovered within the first

acquisition point (> 1 s-1), and a slow phase (kslow) recovered with an average rate of
0.060 ± 0.037 s-1 (Table 4).

kslow ranged between 0.013 – 0.15 s-1 in the eighteen

cells examined by TIRF/FRAP, but in all cases kslow was clearly resolved from kfast.
Because myo1c binds acidic lipids at a diffusion-limited rate (Tang, Lin et al. 2002), we
interpreted the slow recovery time to be the rate at which the photobleached GFP-
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myo1c-tail dissociated from the membrane and the fast recovery to have been the
diffusion of GFP-tail in the cytoplasm.
The fluorescence after photobleaching of GFP-tail-K892A and GFP-tail-R903A
almost completely recovered within the first acquisition point at a rate > 1 s-1, a
response similar to control cells expressing GFP alone. Also, no slow phase was
detected, which suggested that the myo1c proteins containing point mutations did not
bind to the membrane. These results were consistent with the in vitro binding data
(Figure 44).
To make certain the motor domain would not compensate for the point
mutations in the tail domain of myo1c, we repeated these experiments with full length,
GFP-tagged constructs. Again, the fluorescence of GFP-myo1c after photobleaching in
TIRF/FRAP experiments recovered in two phases. The kinetics of the recovery phases
were nearly identical to GFP-tail, indicating that the actin binding domain did not
contribute significantly to the lifetime of plasma membrane attachment of the overexpressed protein (Table 4).

The fluorescence after photobleaching of GFP-myo1c-

K892A and GFP-myo1c-K903A almost completely recovered within the first
acquisition point at a rate of > 1 s-1, confirming that the mutations in the full length
protein did not bind tightly to the membrane.

Therefore, we concluded that myo1c

bound to membranes in vitro and in vivo via a region in the tail domain that was in part
structurally homologous to the phosphatidylinositol binding site in certain PH domains.
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Figure 46 TIRF/FRAP of myo1c-tail constructs

Figure 46: Figure was originally published in (Hokanson, Laakso et al. 2006).
TIRF/FRAP experiments of single NRK cells expressing (top row) GFP-tail,
(center row) GFP-tail-K892A, and (bottom row) GFP-tail-R903A.

(Left

column) TIRF micrographs of NRK cells before photobleaching. The boxes
outline the photobleached regions. The scale bar is 15 µm. (Center columns)
Normalized time-lapse images of the photobleached regions (see chapter 2);
elapsed times are given relative to the start of the bleach pulse. (Right column)
Fluorescence recovery of GFP after photobleach. The bleach pulse occurs at
time-zero. The solid line in the top graph is a fit of the data from this cell to the
sum of two exponential rates (kslow = 0.10 ± 0.010 s-1).
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3.5.2 Myo1c Tail Domain is Sufficient for Membrane Localization

To test whether the IQ motifs in the regulatory domain are necessary for
membrane binding in live NRK cells, we performed TIRF/FRAP microscopy of GFPmyo1c-tailIQ2-3, GFP-myo1c-tailIQ3, and GFP-myo1c-tailIQ0 (Figure 11).

The

fluorescence after photobleaching of these constructs recovered in two phases, as seen
with GFP-tail (Table 4). The fast phases recovered within the time resolution of the
experiment (> 1 s-1), and the slow phases recovered with average rates between 0.041 –
0.049 s-1, which were not significantly different from the kslow determined for GFP-tail.
Therefore, the regulatory domain was not necessary for membrane association in vivo.
However, this finding did not rule out a role for the regulatory domain in targeting the
motor to specific subcellular regions.
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Table 4 Rates of fluorescence recovery from TIRF/FRAP experiments.

a

Myo1c constructa

kslow (s-1)b

Rangec

GFP-tail (18)

0.060 ± 0.037

0.013 – 0.15

GFP-myo1c (10)

0.050 ± 0.028

0.017 – 0.096

GFP-tail-K892A (4)

> 1 s-1

> 1 s-1

GFP-tail-R903A (7)

> 1 s-1

> 1 s-1

GFP-myo1c-K892A (7)

> 1 s-1

> 1 s-1

GFP-myo1c-R903A (9)

> 1 s-1

> 1 s-1

GFP only (4)

> 1 s-1

> 1 s-1

GFP-myo1c-tailIQ2-3 (11)

0.049 ± 0.028

0.018 – 0.087

GFP-myo1c-tailIQ3 (16)

0.050 ± 0.021

0.019 – 0.089

GFP-myo1c-tailIQ0 (15)

0.041 ± 0.012

0.012 – 0.094

The number of FRAP transients is reported in the parentheses.

b

Values of kslow were determined from fitting the data to the sum of two
exponential transients. Values of kfast determined from the fits are as fast as
the time resolution of the acquisitions and are not reported. Errors are
standard deviations.
c

The minimum and maximum values for the experimental set of kslow values.
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4 Discussion
This chapter will interpret the results from chapter 3 and foresee their
implications on the association of myo1c with the plasma membrane. Included will be
the relevance of PIP2 binding and the resulting specific interaction of myo1c with the
membrane. The binding domain will be modeled and the mechanism of binding will be
related to other membrane binding, as well as the force and dynamics of motors while
bound to the membrane.

4.1 Mechanism of Membrane Binding
4.1.1 Original Hypothesis

It has been known since 1989 that myosin-Is are localized to the plasma
membrane and bind to vesicles of anionic lipids (Adams and Pollard 1989). Myo1c has
been shown to bind to LUVs composed of increasing molar concentrations of PS with
increasing affinity (Tang, Lin et al. 2002). The regulatory and tail domain of myo1c has
clusters of positively charged arginines and lysines, with an estimated pI of 10.8.
Before this study, it was believed that the association of myo1c with the plasma
membrane was primarily based on non-specific electrostatic interactions (Hayden,
Wolenski et al. 1990; Doberstein and Pollard 1992). We initially modeled one patch of
basic residues, PEWKQQLQQKAVASEIFKGKK, as an α-helix using Swiss PDB
Viewer (Figure 47A-B); it appeared as an amphiphatic helix with all of the basic
charges aligned on one side of the helix. Therefore, we originally predicted this cluster
of positive charges to be the lipid binding site of myo1c.
132

Figure 47 Predicted lipid binding site

Figure 47A-B: A predicted α-helix calculated with Swiss PDB viewer and
stylized using Pymol. The structure was predicted using energy minimizations of
the sequence from the text. A) Predicted α-helix, basic residues are displayed in
blue, aromatic residues are displayed in gold. B) Electrostatic potential map of
the helix in “A”. Note the amphiphatic nature of the helix with basic residues
facing the top side.
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4.1.1.1 Electrostatic Binding

Like myo1c, MARCKS has been shown to bind PS through electrostatic
interactions (McLaughlin, Wang et al. 2002). The ED of MARCKS has been well
studied and contains 13 basic residues, five phenylalanines, and a myristoylated Nterminus (Figure 8). MARCKS has no set structure when it is bound or unbound to the
membrane (Arbuzova, Schmitz et al. 2002). It combines myristoylation, hydrophobic
insertions, and electrostatic interactions to bind to the plasma membrane in a nonspecific manner. Based on binding data from MARCKS (McLaughlin, Wang et al.
2002) and helical reconstructions of a myosin-I showing the lack of electron density in
the tail domain (Figure 48) (Jontes and Milligan 1997), we initially hypothesized that
myo1c bound to the membrane in a non-specific manner similar to the ED of
MARCKS. We further hypothesized that the structure of the myo1c tail domain might
be disordered and that interacting with the membrane could induce the folding of an
amphiphatic helix, creating a highly concentrated positive electrostatic potential that
would bind to the negatively charged membrane. Membrane localization of the ED of
MARCKS requires an interaction with multiple PS molecules. It was predicted and
subsequently demonstrated that the ED preferentially bound to lipid headgroups in
which the negative charges were already clustered. The prime candidate for a lipid with
such a head group was PIP2, which has a charge of -4 at pH 7 (McLaughlin, Wang et al.
2002).

Since PIP2 only contributes ~ 1% of the plasma membrane, the binding

interaction between myo1c and PIP2 would have to require a tight 1:1 stoichiometry of
myo1c : PIP2, or a cooperative binding to multiple PIP2 molecules.
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Figure 48 3D model of myo1a

Figure 48A-C: A three dimensional model of myo1a from (Jontes
and Milligan 1997). A) M, motor domain; LC1, 2, and 3, the three
CaM light chains; LB, lipid binding domain. The deduced actin
binding site is indicated by the arrow. The plane of the membrane
is illustrated by the dotted lines. B) and C) are side views of the
model. The scale bar represents 45 Å.
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4.1.1.2 Myo1c Binds PIP2 Headgroup

To determine if MARCKS’s non-specific binding mechanism was an
appropriate model for the interaction between myo1c and PIP2, we measured the
binding of myo1c-tail to PIP2 and found that like MARCKS, myo1c bound PIP2
preferably over PS (Table 1).

However, unlike proteins with polybasic EDs,

(McLaughlin, Wang et al. 2002) , the interaction did not appear to be cooperative, as
determined by the lack of a lag phase when myo1c bound to increasing molar
concentrations of PIP2 (Figure 29). In addition, myo1c was unable to cluster multiple
PIP2 molecules together upon binding to the membrane, as measured by FRET.
Moreover, we determined that myo1c bound to Ins(1,4,5)P3 directly, and that this
interaction was slightly tighter than that for PIP2. Proteins with polybasic EDs cannot
bind to soluble inositol phosphates derivatives because they are not presented in a
multivalent manner within the membrane like phosphatidyl inositols. This is referred to
as a reduction of dimensionality and can increase the effective concentration of a
substrate 1000-fold (Adam 1968). Thus, the interaction of myo1c for PIP2 was not
cooperative, but specific for the headgroup of the lipid. This led us to form a new
hypothesis that the mechanism of myo1c binding to the membrane was more similar to
the specific interaction of PLCδ-PH with PIP2 (Lemmon and Ferguson 2001) rather
than the electrostatic interaction of the polybasic ED of MARCKS with multiple PIP 2
molecules.
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4.1.2 Myo1c Tail Domain Binds PIP2

We now know that myo1c binds to the membrane through a specific interaction
with the head group of PIP2 and other phosphatidyl inositols. The myo1c tail domain is
necessary and sufficient to localize myo1c to the membrane.

This high affinity

interaction drives the association of myo1c to the plasma membrane and other
membrane regions rich in poly-phosphatidyl inositols. We show through sedimentation
assays that myo1c binds PIP2 with a partition coefficient of Keffacidic = 0.23 µM. The
interaction of myo1c with PIP2 has a 1:1 stoichiometry as evidenced by our data from
PIP2 molar percentage experiments, as well as our data showing that myo1c can bind to
Ins(1,4,5)P3. All evidence points to a similar binding mechanism to the canonical PIP2
binding PLCδ-PH domain. This similarity is further supported by our data showing that
mutating one of two conserved residues of the PH domain signature motif, both
essential for PIP2 binding in certain PH domains, in the myo1c-tail completely
eradicates binding to PIP2 and membrane localization.
Many PH domains contain a specific binding pocket for the phosphorylated
inositol rings of phosphatidyl inositols.

These pockets are made up of multiple

hypervariable loops that form hydrogen bonds to the phosphates on the inositol rings of
phosphatidyl inositols (Lemmon and Ferguson 2001). The first of these loops between
β-strand 1 and β-strand 2 is where the PH domain signature motif lies. Slight variations
in the non-conserved residues found on these loops give rise to the binding specificity to
particular phosphatidyl inositols (Cronin, DiNitto et al. 2004).

We found that myo1c

bound promiscuously to many inositol phosphates through our competitive inhibition
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assays. Although no structure is known for the tail domain of myo1c, we hypothesize
that it contains a binding pocket made up of loops containing basic residues required for
hydrogen bonding with the phosphates of phosphatidylinositols.

Myo1c shares

sequence homology with many other myosin-I isoforms from vertebrates and other
eukaryotes; slight differences in the non-conserved residues of these loops may lead to
stereo-specific interactions with particular phosphatidyl inositols, much like that seen in
the hypervariable loops of PH domains (Lemmon and Ferguson 2001). This would lead
to an isoform specific localization of myosin-Is in the cell due to the non-uniform
expression and localization of phosphatidyl inositols. Although all of our membrane
binding data with myo1c supports characteristics of its tail domain containing a
phosphatidylinositol binding PH domain, we are unable to classify it as a PH domain
because no structure is known.

4.1.3 Biological Relevance of PIP2 Binding

Phosphatidylinositols are concentrated in actin-rich structures where they
regulate the activity of several cytoskeletal proteins, including activators of the Arp2/3
complex, actin severing and capping proteins, and actin monomer binding proteins
(Insall and Weiner 2001; Yin and Janmey 2003).

PIP2 production spatially and

temporally regulates phagocytosis, macropinocytosis, endocytosis, ion channel function
and cell protrusion. Myosin-I isoforms are also enriched in these regions and function in
these processes (Yin and Janmey 2003). One role of phosphatidylinositols in actin-rich
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structures may simply be to serve as spatially and temporally regulated membrane
anchors for myosin-I isoforms, allowing the recruitment of myosin-I to function in
endocytosis (Novak, Peterson et al. 1995; Jung, Wu et al. 1996; Swanson, Johnson et al.
1999; Ostap, Maupin et al. 2003), secretion (Bose, Guilherme et al. 2002), and
membrane retraction. However, myosin-I isoforms may also use their barbed-enddirected motor activity to keep the fast-growing ends of the actin filament oriented
toward the membrane and phosphatidylinositol regulators of the cytoskeleton (Jung,
Remmert et al. 2001).
Myosin-I isoforms may also link phosphatidylinositols to other regulatory
proteins. For example, -catenin and dynamin have been shown to bind myosin-I in
Drosophila, where they play a role in the control of left-right asymmetry during
development (Hozumi, Maeda et al. 2006; Speder, Adam et al. 2006). However, the
function of myosin-I in these processes is not understood, and it is not known if the
motor and phosphatidylinositol binding activity of myosin-I drives the localization of
these proteins, or if myosin-I is targeted to specific regions by binding to these proteins.
PHR1, a recently identified integral membrane protein present in the sensory cells of the
inner ear, binds myo1c and may link it to stereocilia membranes (Etournay, El-Amraoui
et al. 2005). Myo1c is the likely motor that drives mechanical adaptation in hair cells
(Batters, Arthur et al. 2004; Gillespie and Cyr 2004), and depletion of PIP2 inhibits this
adaptation (Hirono, Denis et al. 2004). Therefore, it is likely that PHR1 and PIP2 act to
link myo1c to the adaptation complex (Hirono, Denis et al. 2004; Etournay, El-Amraoui
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et al. 2005). It is interesting to speculate that control of the levels of membrane
phosphatidylinositol regulates the assembly of this motor complex.

4.1.4 The Regulatory Domain and Membrane Association

The original hypothesis of a membrane induced, α–helical binding site could
still hold true for a separate, secondary membrane binding site. In fact, our data showed
that there was an electrostatic component to the binding of myo1c to the membrane,
given that myo1c bound to LUVs comprised of ≥ 60% PS and that the addition of NaCl
was able to inhibit binding of myo1c to either LUVs of PS or PIP 2. However, it is more
likely that our data supports a model which implicates the regulatory domain as the
secondary binding site of myo1c (Swanljung-Collins and Collins 1992; Tang, Lin et al.
2002; Hirono, Denis et al. 2004). This model was derived from the existence of several
basic residues in the three IQ motifs of the regulatory domain.

A Ca2+-induced

conformational change or dissociation of one or more of the three CaM bound to the IQ
motifs could reveal positive charges (Figure 31).
Our sedimentation assays confirmed that the regulatory domain of myo1c was
capable of binding negatively charged phospholipid membranes in vitro in a Ca2+dependent manner, as proposed for myo1a (Collins and Swanljung-Collins 1992) and
myo1c (Tang, Lin et al. 2002; Hirono, Denis et al. 2004). A myo1c construct lacking
the tail domain but still containing the regulatory domain was able to bind to LUVs
comprised of ≥ 40% PS with high affinity in the presence of 10 µM Ca 2+. We also
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found that the affinity of the myo1c-tail interaction increased ~5-fold with the inclusion
of 20% PS in LUVs that contained 2% PIP2. This indicated that the regulatory domain
could potentially play a secondary role in membrane attachment, with the primary
association occurring via phosphatidylinositol-tail interactions.

Nevertheless, this

secondary binding site alone could not explain the physiological binding of myo1c to
the membrane since the typical inner leaflet of the membrane contains less than 30%
PS. For myo1c to bind to the plasma membrane in a cell, it must rely on its primary
lipid binding site in the tail domain.
TIRF/FRAP experiments revealed that the regulatory domain was not necessary
for plasma membrane association in live cells. Although the high expression levels of
the GFP constructs and the short acquisition integration time prevented us from
confidently examining subtle changes in subcellular localizations, we were able to
detect membrane binding of GFP-myo1c-tailIQ0 with dissociation rates similar to GFPmyo1c. One can speculate that although the motor and regulatory domains are not
required for membrane association, they may have an effect on the subcellular
localization to micro domains on the membrane. In fact, the motor domain has been
shown to be required for correct subcellular localization of other myosin-Is (Ruppert,
Godel et al. 1995; Tang and Ostap 2001; Bahler and Rhoads 2002); however, our IQ
motif deletion constructs did not contain a motor domain, so we could not study this
directly. Although we could rule out the requirement of the regulatory domain for
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plasma membrane attachment, further experiments are required to determine its role in
myosin-I targeting (Cyr, Dumont et al. 2002).

4.2 Discovery of the PIP2 Binding Site.
4.2.1 Identifying a Putative PH Domain

We were able to identify the PIP2 binding site of myo1c through discovering
predicted

secondary

structure

homology

to

a

specific

region

in

poly-

phosphatidylinositol binding (PPB) PH domains. This region contained the PH domain
signature motif of conserved basic residues (K-Xn-(K/R)-X-R) (Isakoff, Cardozo et al.
1998; Cronin, DiNitto et al. 2004). We validated this sequence similarity to PPB PH
domains by testing single point mutations in our myo1c construct that are conserved
and known to disrupt PIP2 binding in these domains. As with PPB PH domains that
contain (K-Xn-(K/R)-X-R), these point mutations completely eradicated myo1c binding
to PIP2 in vitro and disrupted membrane localization in vivo. These data supported our
finding that the tail domain of myo1c is both sufficient and necessary for membrane
localization in the cell.
In a collaboration with Dave Sept (Washington University, St. Louis, MO), we
preformed ab initio structural prediction calculations of residues P802-R1028 within the
myo1c tail domain. These calculations resulted in a modeled structure that could not be
classified as a PH domain, but showed some structural similarity to PH domains (see
chapter 2). These similarities included the β1-loop-β2 region (Figure 49B) and a 142

sheet core structure, although it was not continuous (Figure 49A). Specifically, when
compared with the PH domain of PDK1, we saw that the structural alignment over the
β1-loop-β2 region was very good (Figure 49), giving a protein backbone RMSD of 3.5
Å with a sequence identity of 61% (Figure 43). However, the computation predicted
neither a seven stranded β-sheet core, nor a distinct C-terminal α-helical cap as defined
in all PH domain structures (Lemmon and Ferguson 2001), which may have been a
limitation of the computational method, or may reflect actual differences in the
structure.

Figure 49 Predicted PIP2 binding structure

Figure 49A-B: Figure was originally published in (Hokanson, Laakso et al. 2006).
A) Predicted structure for the myo1c tail region (orange) compared with the Pdk1
structure (green). (B) Detailed comparison of the β1-loop-β2 region of PDK1 and
the predicted structure of the Myo1c tail. Two of the residues in Pdk1 involved in
coordinating the Ins(1,3,4,5)P4 molecule align with our two mutations at K892 and
R903 (see sequence inset).
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Since our ab initio modeling cannot identify a PH domain in the myo1c tail, it is
possible that this region is a novel PIP2 binding motif with only partial sequence and
structural elements similar to PH domains. It is also possible, and perhaps likely, that
the ab initio model is wrong. Low electron density of the tail domain from electron
microscopy and helical reconstructions suggests this region may be flexible (Jontes and
Milligan 1997). A flexible region could enable a myo1c bound to PIP2 to bind to an
actin filament at various places along its helical pitch. Therefore, more binding sites
would be available on a given actin filament, which would increase the chance of it
binding to myo1c as it approaches the membrane from varying angles.
This alternative model is quite intriguing since it may lead to the discovery of a
new phosphatidyl inositol binding domain found among the short-tail vertebrate
myosin-Is, as well as myosin-Is from many other eukaryotes. As discussed earlier,
slight differences in sequence could lead to subtle changes in spatial or temporal
localization. Defining this binding site is an important step in our understanding of the
interaction between myosin-Is and the membrane.

Knowing which residues are

important to membrane binding will help in the understanding of diseases and drug
targeting involving myosin-I motors.
Further characterizing this domain will also help in understanding the seemingly
redundant nature of expressing multiple myosin-I isoforms in the same cell. It has been
shown that knocking down the expression of a single myosin-I isoform shows little to
no phenotype in some cells because there are complimentary myosin-I isoforms that
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will take its place (Jung, Wu et al. 1996). In fact, a myo1a knock out mouse showed
ectopic recruitment of myo1c to the region where myo1a normally resides (Tyska,
Mackey et al. 2005). In many of the cases studied, there appears to be an overlap of
localization as well as function. Myo1c and myo1e are both found at the vesicles
containing cortical granules within a short time span, yet play unique roles (Sokac,
Schietroma et al. 2006; Schietroma, Yu et al. 2007). We found no obvious dominant
negative effects from the over-expression of either GFP-tail or GFP-myo1c-R902A
(Figure 40). To further define the membrane binding domain, detailed structural
information is imperative. This will allow a better understanding of the structural
diversity within the myosin-I isoforms needed to decipher their overlapping, but
possibly non-redundant functions.

4.2.2 Inositol Phosphate Specificity

We showed through gel filtration and competitive binding assays that myo1c
bound to inositol phosphates directly with similar affinities to PIP2. These affinities
were similar to those of PH domains specific for inositol phosphate Ins(1,4,5)P3,
including PLCδ, Kd = 0.21 µM (Lemmon, Ferguson et al. 1995), Ins(1,3,4,5)P4,
including Btk, Kd = 0.040 µM (Baraldi, Carugo et al. 1999), and Pdk1, Kd = 0.014 µM
(Komander, Fairservice et al. 2004). We found that although myo1c seemed to be quite
promiscuous and bound to most of the inositol phosphates with affinities within a factor
of three, it bound to Ins(1,2,6)P3 with a 10-fold weaker affinity and did not bind
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Ins(3)P1 detectably. Therefore, the binding affinity was not based on the charge of the
inositol phosphate alone, but was dependent on the positions of the phosphates on the
inositol ring. Our experiments suggested that phosphates at the 4 or 5 positions were
required for tight binding, while phosphates at the other positions did not prevent
binding.
Myo1c should be able to bind lipids that have headgroups listed in Table 3, with
PIP2 (Ins(1,4,5)P3 headgroup) and PIP3 (Ins(1,3,4,5)P4 headgroup) being the most
prevalent in the membrane and the most relevant to the proposed functions of myo1c
(Yin and Janmey 2003). The plasma membrane concentration of PIP2 is much higher
than PIP3 in both unstimulated and stimulated cells (Insall and Weiner 2001; Dormann,
Weijer et al. 2002). Thus, in the absence of other phosphatidylinositol binding proteins,
we would expect myo1c to interact with PIP 2 based on its higher concentration
(McLaughlin and Murray 2005). However, our in vitro biochemical experiments may
not take into account the presence of other cellular phosphatidylinositol binding
proteins. Further cellular experiments are required to determine in vivo specificity and
binding of myo1c.

4.2.3 Phosphatidylinositol Binding by Other Myosin-I Isoforms

Alignment of myo1c with the seven other vertebrate myosin-I isoforms showed
sequence conservation in the β1-loop-β2 motif region of the putative PH domain. The
highest sequence similarity was among the short tail myosin-I isoforms (myo1a, myo1b,
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myo1c, myo1d, myo1g). Thus, we proposed that the short-tail isoforms will bind to
phosphatidylinositols in a manner similar to myo1c. We also found extended sequence
similarities of this region to myosin-Is from other species including 61F and 31DF from
Drosophila, hum-5 and hum-1 from C. elegans, and Myo3 and Myo5 from S.
cerevisiae. However, given that this region was not completely conserved, it is possible
that the different short-tail isoforms differ in their phosphatidylinositol affinity and
specificity. This would enable different myosin-I isoforms to localize to different subregions

on

the

plasma

membrane

depending

on

local

concentrations

of

phosphatidylinositols.
Long-tail myosin-I isoforms have been shown to bind acidic phospholipids
(Adams and Pollard 1989; Miyata, Bowers et al. 1989; Stoffler, Ruppert et al. 1995).
However, vertebrate long-tail myosin-I isoforms (myo1e and myo1f) contain only the
N-terminal portion of the PH domain signature motif. Although their sequences diverge
from the signature motif in the putative loop region, they do contain several positive
charges that may be positioned for phosphatidylinositol binding. It is possible that
without hypervariable loops like those found in PPB PH domains, myo1e and myo1f
may bind to the membrane in a manner more similar to the ED of MARCKS than to a
PH domain.
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4.3 Myo1c Lipid Binding Sites
4.3.1 Physiological Role of Binding PIP2

We hypothesize that since levels of PIP2 in the inner leaflet of the plasma membrane
are estimated to be 5 - 10 µM, which is 10 – 1000 fold higher than most other
phosphatidyl inositols (PtdIns4P is 3 µM) (Stephens, Jackson et al. 1993; McLaughlin,
Wang et al. 2002), myo1c will more often bind PIP2 preferentially over other
phosphatidyl inositols. This leads to important implications within the cell including
subcellular localization, PIP2 sequestering, limited lateral diffusion rates, possible
regulation, and tight binding.

4.3.1.1 Localization to High Concentrations of PIP2 at the Membrane

PIP2 has been implicated to exist at high local concentrations on the plasma
membrane and in membrane structures within the cell (McLaughlin, Wang et al. 2002).
This can be due to synthesis of PIP2 at these regions, sequestering and clustering of PIP2
by proteins, or segregation of PIP2 into micro-domains. A higher local concentration
should result in the recruitment of myo1c. This not only affects the spatial localization
of myo1c, but also the temporal localization; additionally, the local concentrations of
PIP2 in the cell can be very dynamic. We have shown an example of this in NRK cells
where myo1c tracks with a macropinosome enriched with PIP2. One of the most
important implications of high local concentrations of PIP2 for myo1c is the role of
myo1c as a motor in the adaptation response in hair cells.
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4.3.1.2 Role of PIP2 Binding in Hair Cells

PIP2 has a distinct distribution in hair cells, being present only above the ankle link
region of stereocilia and excluded from the basal region and apical surface of hair cells
(Hirono, Denis et al. 2004). Inhibition of PIK4 reduces the rates of both slow and fast
adaptation and causes a loss in transduction current (Hirono, Denis et al. 2004). Myo1c
is required for the slow and fast adaptation in hair cells (Holt, Gillespie et al. 2002;
Gillespie 2004), and it has been shown that the second IQ motif is necessary for proper
myo1c localization in stereocilia (Cyr, Dumont et al. 2002; Phillips, Tong et al. 2006).
The second IQ motif of myo1c is thought to interact with the cytoplasmic domain of
cadherin 23, a component of the tip link, but is not sufficient for proper localization
(Siemens, Lillo et al. 2004; Phillips, Tong et al. 2006). From these and other studies it
is clear that the mechano-signal transduction and the adaptation response in hair cells
requires both PIP2 and myo1c.
We hypothesize that disrupting PIP2 levels in hair cells disrupts the ability of myo1c
motors to be linked to the transduction channel and facilitate an adaptive response. One
model that would explain this is that myo1c binds to PIP2 through its tail domain and
cadherin 23 through its second IQ motif, linking myo1c to both the transduction
apparatus and to the surrounding membrane while it is bound to the bundled actin
filaments through its motor domain. These interactions could cluster the estimated
ensemble of 50 – 200 myo1c motors to the transduction apparatus and enable them to
adapt to the transduction channel opening. Without either of these interactions present,
transduction ceases and adaptation is lost.
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An opposing model is that the IQ motifs bind to both cadherin 23 and PIP2. Since
the IQ motifs of myo1c are highly basic, it is reasonable to assume that they could
provide a secondary binding sight to a high local concentration of PIP 2 and would be
sufficient for localization. In fact, this has been confirmed using PIP strips (Hirono,
Denis et al. 2004) and a myo1c construct containing only the IQ motifs. However, we
believe that this interaction is not physiological and only exists due to the abnormally
high density of PIP2 present on the PIP strips, as our myo1c-motor construct did not
bind to up to 10% PIP2 LUVs. Any positively charged peptide is likely to bind to PIP
strips; however, this does not mean that it will bind to PIP2 at physiological
concentrations in the cell. Therefore, I believe that the IQ motifs are responsible for
binding to cadherin 23 or another transduction apparatus receptor, and that the tail
domain is responsible for binding to PIP2.

4.3.1.3 Sequestering PIP2

We showed that myo1c is unable to cluster multiple PIP2 molecules together;
however, one can imagine how multiple myo1c molecules decorating an actin filament
might be able to align a string of PIP2 molecules along the actin filament. In a branched
network of actin filaments close to the plasma membrane, this could create a high
density of PIP2 molecules that have a low lateral diffusion coefficient and are unable to
bind to other proteins. A secondary effect of this is that if PIP2 binds laterally to
intermembrane proteins, this would give rise to the pickets in the picket fence model
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that correlates with the mesh size of the actin cytoskeleton. More on this will be
discussed later.

Through a signaling event or regulation of myo1c, these PIP2

molecules could be released, creating a local high concentration of PIP2 for other
proteins to bind. This has been shown previously with MARCKS protein which can
bind to multiple PIP2 molecules (Glaser, Wanaski et al. 1996).
Our digestion experiments with trypsin revealed that myo1c is protected from
digestion in the presence of Ins(1,4,5)P3. Binding to PIP2 in the cell may protect myo1c
from being degraded by protecting sites targeted by proteinases.

Selecting non-

membrane bound myo1c for degradation could be a way to regulate the over-expression
of myo1c and limit its presence in the cytoplasm.

4.3.2 Physiological Role of the Regulatory Domain in Membrane Association

The primary proposed role of the regulatory domains of all myosins is that it
acts as a lever arm that transduces the force of the motor domain. It has been shown
that light chains, most likely CaM, bind to the long single α-helix to give it enough
rigidity to hold firmly in place during a powerstroke. Without light chains bound, it is
thought that the lever becomes flaccid (Zhu, Beckingham et al. 1998). From our
binding data collected with the myo1c-motor construct and myo1c-tail with LUVs of
20% PS and 2% PIP2, it is apparent that the regulatory domain plays a role in membrane
binding. Once myo1c has been localized to the plasma membrane via the tail domain
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binding to PIP2, it is likely that at least one of the IQ motifs will contribute to binding
by a conformational change or dissociation of a CaM.

4.3.2.1 Sequestering of the Lever Arm

One consequence of the regulatory domain binding to the membrane is that it
will shorten the effective lever arm of the motor considerably depending on which of
the IQ motifs binds to the membrane. Myo1c has a powerstroke of 4.2 nm (Batters,
Arthur et al. 2004) and it has been shown that the number of IQ motifs linearly affects
the length of the working powerstroke of myosin-V (Sakamoto, Wang et al. 2003). If
the IQ motif furthest from the motor domain loses its CaM and binds to the plasma
membrane, it will essentially change the length of the powerstroke from three IQ motifs
to two. This shortening of the lever arm could be a way to regulate the length of the
powerstroke in the cell. However, if the IQ motif closest to the motor is affected, it will
also shorten the length of the powerstroke considerably. This would have a drastic
affect on the function of the myo1c and may even inhibit it from acting as a
conventional molecular motor. In this latter case, myo1c would instead act as a very
short tether, maintaining a bond between the actin cytoskeleton and the plasma
membrane.
Although an IQ motif providing an additional binding site to the plasma
membrane may shorten the length of the powerstroke, it may provide an additional
anchoring point. As will be discussed later in more detail, for a myosin-I to be an
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effective motor while it is bound to the membrane, it must remain anchored in the
membrane and not fluid during a powerstroke. Although it has been shown that PIP2
has a much lower lateral diffusion rate than other lipids (Cho, Kim et al. 2005), an
additional binding site to multiple PS molecules may stabilize myo1c positioning on the
membrane.

4.3.2.2 Stabilizing Myo1c in the Absence of CaM

Another possibility for the function of the regulatory domain in myo1c binding
to the plasma membrane is to prevent the aggregation of myo1c. Ca2+ was found to
prevent myo1c from dissociating from 60% PS LUVs, even after washout with EGTA
(Tang, Lin et al. 2002). This suggests that in the presence of excess Ca2+, myo1c
binding to the membrane is irreversible in the absence of excess CaM. Myosins are
notorious for aggregating when they are in the absence of light chains. When a CaM
dissociates from myo1c, binding to the membrane may be a way for myo1c to prevent
aggregation, thus stabilizing its regulatory domain and preventing it from binding to
potentially harmful binding partners that would cause aggregation.

Therefore, the

plasma membrane could act much like a chaperone protein, binding to unstable regions
of the protein until a light chain is available for binding.
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4.3.2.3 Lower Dissociation Rates

We propose that the main function of the regulatory domain of myo1c bound to
the membrane is that it changes the kinetics of membrane association by decreasing the
dissociation rate.

The Kefflipid increases 10-fold when 20% PS is added to LUVs

comprised of 2% PIP2. Since association rates are fast and diffusion limited (Tang, Lin
et al. 2002), the only way to explain this is that the dissociation rates decrease 10-fold.
This would allow myo1c to proceed through more ATPase cycles (1 s-1) while still
bound to the membrane if it is acting as a motor, or keep myo1c associated with the
membrane longer if the primary role of myo1c bound to the plasma membrane is to act
as a tether.

4.4 Force and Function.
The apparent second-order association rate (ka) of myo1c for 60% LUVs is
~0.16 µM-1 s-1. For binding in terms of LUV concentrations, this rate can be considered
as diffusion limited at 2 x 1010 M-1 s-1. (Tang, Lin et al. 2002). We measured the
partition coefficient of myo1c to 2% PIP2 + 20% PS LUVs to be Kefflipid = 4.0 ± 1.5 µM.
If we ignore that Kefflipid is not a true Kd, and that the association rate for 60% PS LUVs
is the same as for 2% PIP2 + 20% PS LUVs, we can calculate a dissociation rate in
accordance with:
Equation 9

𝐾𝑑 =

𝑘𝑑
𝑘𝑎
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An apparent kd calculated as 0.040 s-1 for myo1c dissociating from 2% PIP2 + 20% PS
LUVs in vitro. As mentioned, there are limitations to this calculation so this number
should be taken lightly as an approximation.

This calculated value is in close

agreement with the in vivo dissociation rates we measured in our TIRF/FRAP
experiments (0.05 s-1). Since the ATPase rate of myo1c is 1 s-1 (Gillespie, Gillespie et
al. 1999), myo1c should be able to go through ~20 ATPase cycles before dissociating
from the membrane at high ATP concentrations. Whether the ATPase activity of a
myo1c can produce force relative to the membrane to which it is bound will be
discussed below.
It is well established that the plasma membrane is fluid and dynamic. One of the
biggest questions that still remains regarding myosin-Is is if they can act as a motor
while bound to the membrane. When forces are applied in plane with the membrane,
can a myosin-I molecule that is bound remain anchored during a powerstroke? When
forces are applied perpendicularly, can myo1c stay bound to the membrane, thus
stretching and deforming the membrane itself, or will it be pulled off? These are two
fundamental questions that still need to be answered to understand the functions of
myo1c.

4.4.1 Forces Planar to the Membrane

Testing the notion of myo1c remaining anchored in the plasma membrane while
experiencing forces in plane with the membrane is essential to identifying the possible
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functions of myosin-Is (Figure 50). For myo1c to be functional as a motor while bound
to the membrane, it must be stationary at forces up to 2 pN, the estimated force of a
myo1c powerstroke (Gillespie and Cyr 2004). We can estimate the minimum velocity
of an individual powerstroke of myo1c by dividing the powerstroke distance of 4.2 nm
by the lifetime of actin attachment 50 ms (Gillespie and Cyr 2004) to get a velocity of
0.084 µm/s. To withstand forces of up to 2 pN, the drag coefficient of myo1c on the
membrane would have to be greater than 2.4 x 10-11 N·s/µm in accordance with:
Equation 10

𝐹 = 𝑣𝛾
where F is the force against the plane of the membrane, v is the velocity of the
powerstroke, and γ is the drag coefficient. Using the Einstein relation,
Equation 11

𝐷=

𝑘𝑇
𝛾

where D is the lateral diffusion coefficient, and kT is the Boltzman constant at 37 °C,
4.11 x 10-15 N·µm, this would require the lateral diffusion coefficient of a myo1c bound
to the plasma membrane to be less than 1.7 x 10-4 µm2/s.
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Figure 50 Forces planar to the membrane

Figure 50: Cartoon of myo1c producing forces planar to the membrane.
A) Myo1c bound to both actin and PIP2 pre-powerstroke. B) Myo1c
bound to the membrane remains stationary as the actin filament is
translated relative to the membrane after a powerstroke.

C) Actin

filament remains stationary as myo1c bound to PIP2 laterally diffuses in
the membrane after a powerstroke.
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4.4.1.1 Lateral Diffusion

A diffusion coefficient of 1.7 x 10-4 µm2/s is much slower than the diffusion
rates measured for many lipids (6 µm2/s) (Scandella, Devaux et al. 1972) and integral
membrane proteins (0.5-2 µm2/s) (Snapp 2003).

Diffusion rates of phosphatidyl

inositol associated proteins, such as PLCδ-PH domain, have been measured using
FRAP to be close to cytoplasmic diffusion rates (3.5 µm2/s); however, no controls for
the possibility of the dissociation of bleached proteins from the membrane and
association of unbleached protein were shown (Brough, Bhatti et al. 2005).
Additionally, it was found for eGFP-PH123 that the mean-squared deviation in position
did not increase with time and remained close to the limit of position detection (0.03
µm2) (Mashanov, Tacon et al. 2004).
Interestingly, the diffusion rate for PIP2 was recently measured to be as low as
3.9 e-4 µm2/s in mouse arterial myocytes (Cho, Kim et al. 2005). The diffusion rate was
found to be dependent on the cytoskeleton and is ten thousand times slower than other
phosphatidyl inositols measured in the same study.

PIP2 with a lateral diffusion

coefficient of 3.9 e-4 µm2/s would provide the approximate resistance for a myo1c motor
to translate an actin filament in relation to the plane of the membrane during a
powerstroke.
There are many possibilities that could account for the five orders of magnitude
difference in lateral diffusion rates between PIP2 and other lipids. It has been suggested
that lipids can segregate into microdomains created by mismatches in hydrophobic
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thickness, van der Waals interactions, and acyl chain entropy (Marguet, Lenne et al.
2006). Thus, PIP2 could be segregated into these microdomains which may have a
lower overall diffusion rate than the rest of the membrane.

Although PIP2 has a

polyunsaturated chain and should not partition into microdomains without other factors
acting on it (McLaughlin, Wang et al. 2002), studies have shown that some
microdomains are enriched in PIP2 (Golub, Wacha et al. 2004).
A possibility that also accounts for the dependence on the cytoskeleton is that
the lateral diffusion of PIP2 could be limited by the mesh size of the cytoskeleton, a
model commonly referred to as the picket fence model (Sako and Kusumi 1995). In
this model, it is suggested that the actin cytoskeleton acts as a fence that encloses a
domain of lipids and lipid-bound proteins. Transmembrane proteins that are associated
with the cytoskeleton act as pickets in the membrane and further limit the mobility of
lipids from diffusing outside of these domains. The actin cytoskeleton lies close to the
plasma membrane at just 10.2 nm (Morone, Fujiwara et al. 2006). The mesh sizes
created by the actin network differ from cell types, ranging from 0.0027 µm 2 in FRSK
cells and to 0.039 µm2 in NRK cells. These measurements correlate well with the
measured lateral diffusion of a fluorescently labeled phospholipid used in the same
study, which diffused within a compartment of 0.0021 µm2 in FRSK cells and 0.043
µm2 in NRK cells (Morone, Fujiwara et al. 2006). However, this model alone cannot
explain the five magnitude difference in lateral diffusion rates of PIP2 to other
phospholipids. Incorporating the findings that so many proteins bind to PIP2 and not to
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other phospholipids might be enough to explain the lower diffusion rates. The lateral
diffusion rates of these proteins would be limited by the cytoskeleton, thus limiting PIP2
bound to them, while phospholipids not bound to proteins would be free to diffuse.
An alternative explanation is that the low lateral diffusion rates observed for
PIP2 may be the effect of myo1c binding rather than the cause of myo1c having a low
lateral diffusion rate while it is bound to PIP2. The most likely explanation for the five
magnitude lower diffusion rate of PIP2 to other phospholipids is a direct link between
PIP2 and the cytoskeleton. It has been shown that PIP2 levels regulate membrane
dynamics and cell shape by locally increasing and decreasing the interactions between
the plasma membrane and actin cytoskeleton (Raucher, Stauffer et al. 2000). The low
diffusion rate of PIP2 could be the effect of myo1c or another protein linking the
phosphatidyl inositol directly to the cytoskeleton. If PIP2 is linked to the cytoskeleton
through a protein tether, it would significantly inhibit its lateral diffusion, which would
explain the large difference between lateral diffusion rates between PIP2 and other
phospholipids. With the cytoskeleton being within 10.2 nm of the plasma membrane
(Morone, Fujiwara et al. 2006), it is plausible that myo1c may function as a protein
tether, especially given that a similar myosin-I, myo1a, has an estimated length of 22
nm (Jontes and Milligan 1997). However, PIP2 would not be able to anchor myo1c to
the membrane if myo1c is the reason for the lateral diffusion rate of 3.9 x 10-4 µm2/s.
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4.4.2 Force Perpendicular to the Membrane

An alternative function of myo1c bound to the membrane is to deform the
membrane by applying forces perpendicular to the membrane rather than in the plane of
the membrane (Figure 51). We estimate that these interactions will withstand forces
greater than 40 pN because under similar conditions, the detachment forces of myelin
basic protein from the membrane has been measured to be more than 40 pN (Mueller,
Butt et al. 1999). Myo1c could function in the deformation of the membrane to induce
vesicle fusion or scission, as well as lamellipodia and neuronal growth cone retraction
and expansion. The force required to pull out a membrane tether in vitro was measured
to reach ~50 pN and required the coordinated pulling of multiple motors (Leduc,
Campas et al. 2004). At these forces, it is feasible that an ensemble of myo1c motors
bound to PIP2 on the membrane could pull out a membrane tether without being pulled
off the membrane.
It is not necessary for myo1c to actively produce force to function in processes
that deform the membrane. In both endocytic and exocytic events at the membrane,
myo1c may act as a tether, connecting the growing barbed ends of actin filaments to
sites of membrane deformation. This has been proposed as the function of myo1c in
compensatory endocytosis of fertilized Xenopus eggs (Sokac, Schietroma et al. 2006).
Actin polymerization alone can produce forces of up to 1 pN (Footer, Kerssemakers et
al. 2007). Linking the growing ends of actin to the membrane at sites of endocytosis
may induce stall forces on myo1c, keeping it bound to actin in an ADP bound state as
the forming vesicle pulls the myo1c towards the pointed ends of an actin filament. This
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would allow actin filaments to be properly oriented to produce the forces on the plasma
membrane required for vesicle formation.

Figure 51 Forces perpendicular to the membrane

Figure 51: Cartoon of myo1c producing force perpendicular to the
membrane. A) Myo1c bound to both actin and PIP2 pre-powerstroke.
B) Myo1c after powerstroke deforms the membrane as it pulls up
perpendicularly to the membrane.
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4.4.3 Model for Myo1c Recruitment to the Membrane

Myo1c diffusing in the membrane is under no load and acts as a low duty-ratio
motor of 0.05 (Gillespie 2004). Myosin-Is have been shown not to bind to actin that is
saturated with tropomyosin like filaments found in stress fibers. Thus, myo1c will
diffuse until it reaches the dynamic actin network near the plasma membrane that is not
coated with tropomyosin. Near the plasma membrane, myo1c will bind to free PIP2
through its tail domain and then further strengthen its avidity through interactions of its
regulatory domain with anionic lipids. PIP2 and tropomyosin-free actin created by
phosphatidylinositol production or release from sequestering proteins, and the activation
of new actin polymerization respectively, will create newly available binding sites for
myo1c. Myo1c will localize to these areas of high local concentrations of PIP 2 on the
membrane. As myo1c bound to the membrane binds to actin and goes through its
catalytic cycle, the motor will become strained, and its duty ratio will increase at stall
forces (Figure 52).

Myo1c in this state will act as a tether, linking the actin

cytoskeleton to the plasma membrane.
An ensemble of myo1c motors in such a state has been hypothesized to maintain
the tension on transduction channels in hair cells (Batters, Arthur et al. 2004). When
the channel opens and tension is released, the ensemble of motors climbs up the actin
filaments in the stereocilia until the channel is closed and the tension is reset. At the
membrane, myo1c motors are held in an isometric contraction, linking the membrane to
the underlying cytoskeleton; force from actin polymerization will act on the membrane
as barbed ends are kept close to the membrane interface by myo1c (Figure 52). These
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forces have been proposed to be involved in such processes as membrane fusion,
compensatory endocytosis, and neuronal growth cone turning (Bose, Guilherme et al.
2002; Wang, Liu et al. 2003; Sokac, Schietroma et al. 2006). If the strain on myo1c is
below its stall force, myo1c will complete its powerstroke, resulting in the translocation
of the actin filament. This could be the result of a free actin filament, or many myo1c
motors working together to produce a cooperative force. Therefore, an ensemble of
myo1c motors working cooperatively could produce forces necessary to deform the
membrane or even pull out a lipid tubule (Figure 52). In conclusion, myo1c has been
determined be involved in many cellular processes at the membrane involving the actin
cytoskeleton. Although many of the functional details are still elusive, knowing that
myo1c binds tightly to PIP2 is an important step to understanding the possible roles for
myo1c.

164

Figure 52 Model of Myo1c functions at the plasma membrane

Figure 52: Cartoon of 3 possible functions of myo1c
at

the

membrane

involved

in

lamellipodial extention, and exocytosis.
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endocytosis,

4.5 Future Directions
We have characterized the mechanism by which myo1c binds to the plasma
membrane. Myo1c binds to the membrane through a direct interaction with the head
group of PIP2, and through a secondary, electrostatic interaction via the regulatory
domain. There is still more work needed to be done to understand what role the
myosin-I motors play as a link between the cytoskeleton and the plasma membrane. A
full length construct containing the motor and tail domains of myo1c is essential to
properly answer this question, as is a crystal structure of the PIP2 binding region to
better understand the specific binding site for PIP2.

4.5.1 Myosin-I Isoform Phosphatidylinositol Binding Specificity

The characterization of the binding specificities of all of the myosin-I isoforms
will lead to a greater understanding of their non-redundant localization and function in
the cell. All of the short-tail isoforms contain the PH domain signature motif and are
therefore predicted to bind to phosphatidylinositols. Long-tail isoforms have been
shown to bind to the membrane, but do not contain the PH domain signature motif.
Differences in non-conserved residues may lead to stereo-specificity of head group
binding like that seen in PH domains. This would lead to subcellular localization of
different myosin-I isoforms to membranes enriched in specific phosphatidylinositols.
Regulation of phosphatidylinositols through kinases and phosphatases would also
regulate the localization and activity of the myosin-Is that bind to them. Differentiating
the specific phosphatidylinositol binding of the myosin-I isoforms as well as obtaining
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crystal structures of their membrane binding sites will lead to a better understanding of
their specific and non-redundant biological roles.

4.5.2 Forces

Determining the forces that myo1c can apply to the membrane during a
powerstroke will define the functions that it can perform while bound to the membrane.
Binding forces and lateral diffusion coefficients are needed to define these functions,
and knowing these will allow us to better postulate whether or not myo1c will be able to
translocate an actin filament relative to the membrane or deform the membrane. If
myo1c cannot perform either of these functions, it is more likely that it acts as a tether
or tension sensor rather than a motor while bound to the membrane. Finally, a full
length construct is required to determine the possibilities and limitations of a myosin-I
acting as a motor while bound to the membrane.

4.5.3 Regulation

How the interactions of myosin-Is with the membrane are regulated remains
unknown.

Many lipid binding proteins are regulated by the lipids themselves.

Phosphatidylinositol levels at the membrane are highly dynamic and are controlled by
many signaling cascades in the cell. However, this would require binding specifity of
the different myosin-I isoforms. Other modes of regulation involve other proteins
binding to the lipid binding site. One possibility is a protein sterically blocking the lipid
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binding site with binding of another protein to inhibit membrane localization. Also,
binding partners that are themselves membrane bound could enhance the association of
a myosin-I with the membrane. In the case of myo1c, cadherin 23 is a transmembrane
protein that could form a complex with myo1c and the transduction apparatus in the
stereocilia of hair cells. Phosphorylation could also regulate the interactions of a
myosin-I with the anionic membrane by neutralizing the basic charge of its binding site.
Finally, one must consider Ca2+ regulation on the conformation and dissociation of one
or more CaM from the regulatory domain. We have shown that Ca2+ increases the
affinity of the regulatory domain for anionic lipids in vitro. Whether this increased
affinity is physiologically relevant remains to be seen.

4.5.4 Binding Partners

The tail domains of the different short-tailed myosin-Is is the proposed region
responsible for membrane association. However, this does not imply that their only
function is to bind to lipids. The tail domains of myosin are generally thought of as a
cargo binding domain. The tail domains of myosin-Is could have unique binding
partners depending on the isoform. This would explain why there are multiple isoforms
expressed in the same cell and their differing functions. Myo1c has been shown to bind
to PHR1, NEMO, and cadherin 23; however, the function of each of these interactions
is not clear. Determining the binding partners for all of the myosin-I isoforms is an
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important step to complete their characterization and uncover what their biological roles
are at the membrane.
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5 Abbreviations
1. ADP adenosine diphosphate
2. ATP adenosine triphosphate
3. BSA, bovine serum albumin
4. Ca2+, calcium ion
5. CaM, calmodulin
6. CHO, Chinese hamster ovary
7. COS-7, African green monkey cells
8. DAG, diacylglycerol
9. DEAE, Diethylaminoethyl
10. DLS, dynamic light scattering
11. DMEM, Dulbecco's Modification of Eagle's Medium
12. DNTB, 5,5´-dithiobis-(2-nitrobenzoic acid)
13. DTT, dithiothreitol
14. ECL, enzymatic chemilumenscence
15. ED, effector domain
16. EDTA, ethylenediamine tetraacetic acid
17. EF-hand, helix-turn-helix motif
18. EGTA, ethylene glycol tetraacidic acid
19. FBS, fetal bovine serum
20. FL, fluorescein
21. FLAG, polypeptide protein tag (N-DYKDDDDK-C)
22. FPLC, fast performance liquid chromatography
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23. FRAP, fluorescence recovery after photobleaching
24. FRET, fluorescence resonance energy transfer
25. GFP, green fluorescence protein
26. GST, glutathione-S-transferase
27. 3[H]Ins(1, 4,5)P3, tritiated Ins(1,4,5)P3
28. HEK 293T, human embryonic kidney
29. HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
30. HNa100, 10 mM HEPES, pH 7.0, 100 mM NaCl, 1 mM EGTA, 1 mM DTT
31. IgG, immunoglobulin G
32. Ins(1,2,3,5,6)P5, d-myo-inositol-1,2,3,5,6-pentakisphosphate
33. Ins(1,2,5,6)P4, d-myo-inositol-1,2,5,6-tetrakisphosphate
34. Ins(1,2,6)P3, d-myo-inositol-1,2,6-trisphosphate
35. Ins(1,3,4)P3, d-myo-inositol-1,3,4-trisphosphate
36. Ins(1,3,4,5)P4, d-myo-inositol-1,3,4,5-tetrakisphosphate
37. Ins(1,3,4,6)P4, d-myo-inositol-1,3,4,6-tetrakisphosphate
38. Ins(1,4,5)P3, d-myoinositol-1,4,5-trisphosphate
39. Ins(3)P1, d-myo-inositol-3-monophosphate
40. InsP6, d-myo-inositol hexakisphosphate
41. IPTG, isopropyl β-D-1-thiogalactopyranoside
42. K+, potassium ion
43. LUV, large unilamellar vesicle
44. MARCKS, myristoylated alanine rich C kinase substrate
45. MES, 2-(N-morpholino)ethanesulfonic acid
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46. Mg2+, magnesium ion
47. N2, nitrogen
48. NEMO, nuclear factor κB essential modulator
49. NRK, normal rat kidney
50. N-WASP, Neural Wiskott-Aldrich syndrome protein
51. OD, optical density
52. PA, phospatidic acid
53. PBS, phosphate buffered solution
54. PC, phosphatidylcholine
55. PDB, protein data bank
56. PDK1, 3-phosphatidylinositol-dependent protein kinase 1
57. PE, phosphatidyl ethanolamine
58. PG, phosphatidylglycine
59. PH, pleckstrin homology
60. PI, phospophoinositol
61. PI3K, phosphoinositol-3 kinase
62. PIP2, phosphatidyl inositol-4,5-bisphosphate
63. PKC, protein kinase C
64. PLC, phospholipase C
65. PMSF, phenylmethylsulphonyl fluoride
66. PPB poly-phosphatidylinositol binding
67. PPD, p-phenylenediamine
68. PS, phosphatidylserine
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69. RPMI, Roswell Park Memorial Institute medium
70. SDS-PAGE, sodium dodecyl sulfate polyacylamide gel electrophoresis 3HIns(1,4,5,)P3, Tritium labeled Ins(1,4,5,)P3
71. SH3,src homology 3
72. SI, soybean inhibitor
73. TIRF, total internal reflection fluorescence
74. TMR, tetramethylrhodamine
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